<!DOCTYPE html>
<html>
<head>
	<meta name="viewport" content="width=device-width, initial-scale=1">
	<link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.5.0/css/bootstrap.min.css" integrity="sha384-9aIt2nRpC12Uk9gS9baDl411NQApFmC26EwAOH8WgZl5MYYxFfc+NcPb1dKGj7Sk" crossorigin="anonymous">
	<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css">
	<link rel="stylesheet" type="text/css" href="publicationsStyle.css">
	<link rel="stylesheet" type="text/css" href="uniformStyle.css">	
	<title>Publications</title>
</head>
<body>
	<header>
		<div class='big-header'>
			<h1 class = 'mt-3'> Biomedical Technology and Cell Therapy Research Lab </h1>
			<img src=".photos/McGill.png">
		</div>	
			<!-- End header -->
	<div class="topnav" id="myTopnav">
	  <a href="index.html" >Home</a>
	  <a href="publications.html" class="active">Publications</a>
	  <a href="members.html">Members</a>
	  <a href="lab.html">Laboratory</a>
	  <a href="news.html">News</a>
	  <a href="funding.html">Funding</a>
	  <a href="awards.html">Awards</a>
	  <a href="contact.html">Join Us</a>
	  <a href="javascript:void(0);" class="icon" onclick="myFunction()">
	    <i class="fa fa-bars"></i>
	  </a>
	</div>
	</header>


	<div class="content">
		<div class="row">
		  <div class="col-3 ">
		    <div class="nav sideNav sticky-top flex-column nav-pills" id="v-pills-tab" role="tablist" aria-orientation="vertical">
		    	<a class="nav-link active" id="v-pills-home-tab" data-toggle="pill" href="#pill-articles" role="tab" aria-controls="pill-articles-tab" aria-selected="true">Articles</a>
		    	<a class="nav-link" id="v-pills-profile-tab" data-toggle="pill" href="#pill-books" role="tab" aria-controls="pill-books-tab" aria-selected="false">Books</a>
		   		<a class="nav-link" id="v-pills-messages-tab" data-toggle="pill" href="#pill-revBooks" role="tab" aria-controls="pill-revBooks-tab" aria-selected="false">Book Chapters</a>
		    	<a class="nav-link" id="v-pills-settings-tab" data-toggle="pill" href="#pill-patents" role="tab" aria-controls="pill-patents-tab" aria-selected="false">Patents</a>
				<a class="nav-link" id="v-pills-settings-tab" data-toggle="pill" href="#pill-abstract" role="tab" aria-controls="pill-abstract-tab" aria-selected="false">Abstracts</a>
				<a class="nav-link" id="v-pills-settings-tab" data-toggle="pill" href="#pill-refPro" role="tab" aria-controls="pill-refPro-tab" aria-selected="false">Referred Procedings</a>
				<a class="nav-link" id="v-pills-settings-tab" data-toggle="pill" href="#pill-talks" role="tab" aria-controls="pill-talks-tab" aria-selected="false">Invited Talks</a>		      
		    </div>
		  </div>

		  <div class="col-9">
		    <div class="tab-content" id="v-pills-tabContent">
		    	<div class="tab-pane fade show active" id="pill-articles" role="tabpanel" aria-labelledby="pill-articles-tab">
		      		<h1 class="mt-2 mb-2">Articles</h1>
		      		<hr>
		      		<p>[* denotes equal contribution]</p>
			     		<ol>
							<li>
								<p class="auto-style7">Westfall, S., Lomis, N., Singh, S.P., <strong> <strong>Prakash*</strong></strong>, S. (2016)&nbsp; Ferulic&nbsp;acid&nbsp;produced by Lactobacillus fermentum NCIMB 5221 reduces symptoms of metabolic syndrome in Drosophila melanogaster. J. Microbial Biochem. Technology. (Accepted). Ms. No. JMBT-16-242.</p>
							</li>
							<li>
								<p class="auto-style7">Nikita Lomis, Susan Westfall, Leila Farahdel, Meenakshi Malhotra, Dominique Shum-Tim, <strong> <strong>Prakash*</strong></strong>, S. (2016) Human serum albumin nanoparticles for use in cancer delivery: process optimization and in vitro characterization. Nanomaterials. Accepted (Manuscript ID&#8211; 128964).</p>
							</li>
							<li>
								<p class="auto-style7">Urbanska AM, Karagiannis ED, Au AS, Mozafari M, <strong> <strong>Prakash*</strong></strong>, S. (2016) What's Next for Gastrointestinal Disorders: No Needles? Journal of Control Release. 2016 Jan10; 221:48-61.</p>
							</li>  
							<li>
								<p class="auto-style7">Urbanska AM, Bhathena J, Cherif S, <strong> <strong>Prakash*</strong></strong>, S. (2016) Orally delivered microencapsulated probiotic formulation favorably impacts polyp formation in APC (Min/+) model of intestinal carcinogenesis. Artif. Cells Nanomed Biotechnol. 2016; 44(1):1-11.</p>
							</li>
							<li>
								<p class="auto-style7">Kubow S, Iskandar MM, Sabally K, Azadi B, Sadeghi Ekbatan S, Kumarathasan P, Das DD, <strong> <strong>Prakash</strong></strong>, S. Burgos G, Zum Felde T (2016) Biotransformation of anthocyanins from two purple-fleshed sweet potato accessions in a dynamic gastrointestinal system. Food Chem. 2016 Feb 1; 192:171-177.</p>
							</li>
							<li>
								<p class="auto-style7">Block K et al Satya <strong>Prakash</strong> et al (2015). Designing a broad spectrum integrative approach to cancer biology, Seminars in Cancer Biology, 11-25.</p>
							</li>
							<li>
								<p class="auto-style7">Martoni, CJ, Labbe, A, Ganopolsky, JG,  <strong>Prakash</strong> S, Jones, ML. (2015) Changes in bile acids, FGF-19 and sterol absorption in response to bile salt hydrolyase active L. reuteri NCIMB 32042. Gut microbes. 2015;6(1):57-65.</p>
							</li>
							<li>
								<p class="auto-style7">Tomaro-Duchesneau C, Saha S, Malhotra M, Jones ML, Rodes L, <strong>Prakash*</strong> S. (2015) Lactobacillus fermentum NCIMB 5221 and NCIMB 2797 as cholesterol-lowering probiotic biotherapeutics: in vitro analysis. Benef Microbes. 2015 Aug 31:1-10</p>
							</li>
							<li>
								<p class="auto-style7">Wei Shao, Arghya Paul, Laetitia Rodes, Satya <strong>Prakash*</strong> (2015). A New Carbon Nanotube-Based Breast Cancer Drug Delivery System: Preparation and In Vitro Analysis Using Paclitaxel. Cell Biochemistry and Biophysics. 71(3):1405-1414.</p>
							</li>
							<li>
								<p class="auto-style7">Singh S et al  <strong>Prakash</strong> and Simgh TD (2015). Cytotoxicity of alkaloids isolated from Argemone mexicana on SW480 human colon cancer cell line. Pharm Biol. 2015 Oct 6:1-6.</p>
							</li>
							<li>
								<p class="auto-style7">Tomaro-Duchesneau C, Jones ML, Shah D, Jain P, Saha S,  <strong>Prakash*</strong> S. (2014) Cholesterol assimilation by Lactobacillus probiotic bacteria: an in vitro investigation. Biomed Res Int. 2014; 2014:380316. doi: 10.1155/2014/380316. Epub 2014 Sep 11PMID: 25295259.</p>
							</li>
							<li>
								<p class="auto-style7">Amoako-Tuffour Y, Jones ML, Shalabi N, Labbe A, Vengallatore S,  <strong>Prakash</strong> S. (2014) Ingestible gastrointestinal sampling devices: state-of- the-art and future directions. Crit Rev Biomed Eng. 2014; 42(1):1-15. Review.PMID: 25271356</p>
							</li>
							<li>
								<p class="auto-style7">Al Kindi H, Paul A, You Z, Nepotchatykh O, Schwertani A,  <strong>Prakash*</strong> S, Shum-Tim D (2014). Sustained release of milrinone delivered via microparticles in a rodent model of myocardial infarction. J Thorac Cardiovasc Surg. 2014 Jul 31. pii: S0022-5223(14)01004-6.</p>
							</li>
							<li>
								<p class="auto-style7">Urbanska AM, Bhathena J, Cherif S,  <strong>Prakash*</strong> S. (2014) Orally delivered microencapsulated probiotic formulation favorably impacts polyp formation in APC (Min/+) model of intestinal carcinogenesis. Artif Cells Nanomed Biotechnol. 2014 Jul 25:1-11.</p>
							</li>
							<li>
								<p class="auto-style7">Jones ML, Ganopolsky JG, Martoni CJ, Labbé A, <strong>Prakash*</strong> S. (2014) Emerging science of the human microbiome. Gut Microbes. 2014 Jul 11;5(4).</p>
							</li>
							<li>
								<p class="auto-style7">Saha S, Tomaro-Duchesneau C, Rodes L, Malhotra M, Tabrizian M,  <strong>Prakash*</strong> S. (2014) Investigation of probiotic bacteria as dental caries and periodontal disease biotherapeutics.Beneficial Microbes. 2014 Dec 1; 5(4):447-60. doi: 10.3920/BM2014.0011.</p>
							</li>
							<li>
								<p class="auto-style7">Rodes L, Saha S, Tomaro-Duchesneau C, <strong>Prakash*</strong> S. (2014). Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats. Biomed Res Int. 2014; 2014:602832. doi: 10.1155/2014/602832. Epub 2014 May 22.</p>
							</li>
							<li>
								<p class="auto-style7">Jones ML, Tomaro-Duchesneau C, <strong>Prakash</strong> S (2014). The gut microbiome, probiotics, bile acids axis, and human health. Trends Microbiol. 2014 Jun;22(6):306-8. doi: 10.1016/j.tim.2014.04.010. Epub 2014 May 14.</p>
							</li>
							<li>
								<p class="auto-style7">Fakhoury M, Coussa-Charley M, Al-Salami H, Kahouli I,  <strong>Prakash*</strong> S (2014). Use of artificial cell microcapsule containing thalidomide for treating TNBS-induced Crohn's disease in mice. Curr Drug Deliv. 2014; 11(1):146-53</p>
							</li>
							<li>
								<p class="auto-style7">Paul A, Hasan A, Rodes L, Sangaralingam M,  <strong>Prakash*</strong> S (2014). Bioengineered baculoviruses as new class of therapeutics using micro and nanotechnologies: principles, prospects and challenges. Adv Drug Deliv Rev. 2014 May;71:115-30. doi: 10.1016/j.addr.2014.01.004. Epub 2014 Feb 3.</p>
							</li>
							<li>
								<p class="auto-style7">Jones ML, Martoni CJ, Ganopolsky JG, Labbé A,  <strong>Prakash*</strong> S. (2014). The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention. Expert Opin Biol Ther. 2014 Apr;14(4):467-82. doi: 10.1517/14712598.2014.880420. Epub 2014 Jan 30.</p>
							</li>
							<li>
								<p class="auto-style7">Gundala SR, Mukkavilli R, Yang C, Yadav P, Tandon V, Vangala S,  <strong>Prakash*</strong> S, Aneja R (2014). Enterohepatic recirculation of bioactive ginger phytochemicals is associated with enhanced tumor growth-inhibitory activity of ginger extract. Carcinogenesis. 2014 Jun; 35(6):1320-9. doi: 10.1093/carcin/bgu011.PMID:24431413.</p>
							</li>
							<li>
								<p class="auto-style7">Rodes L, Saha S, Tomaro-Duchesneau C, and <strong>Prakash*</strong> S. (2014) Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 Favorably Modulates Gut Microbiota and Reduces Circulating Endotoxins in F344 Rats. Biomed Res Int. 2014; 2014:602832. doi: 10.1155/2014/602832. Epub 2014 May 22. PMID:24967382</p>
							</li>
							<li>
								<p class="auto-style7">Jones ML, Tomaro-Duchesneau C, and  <strong>Prakash*</strong> S. (2014) The gut microbiome, probiotics, bile acids axis, and human health. Trends Microbiol. 2014 Jun;22(6):306-8. doi: 10.1016/j.tim.2014.04.010. Epub 2014 May 14.PMID:24836108</p>
							</li>
							<li>
								<p class="auto-style7">Fakhoury M, Coussa-Charley M, Al-Salami H, Kahouli I, and  <strong>Prakash*</strong> S. (2014) Use of artificial cell microcapsule containing thalidomide for treating TNBS-induced Crohn's disease in mice. Curr Drug Deliv. 2014 Feb; 11(1):146-53.</p>
							</li>
							<li>
								<p class="auto-style7">Hamood Al Kindi 1, Arghya Paul 2, Zhipeng You3, Oleg Nepotchatykh4, Adel Schwertani3, Satya  <strong>Prakash</strong>2, Dominique Shum-Tim1* (2014) Sustained Release of Milrinone Delivered via Microparticles in a Rodent Model of Myocardial Infarction. The Journal of Thoracic and Cardiovascular Surgery. 2014 Jul 31. pii: S0022-5223(14)01004-6. doi: 10.1016/j.jtcvs.2014.07.033</p>
							</li>
							<li>
								<p class="auto-style7">Jones ML, Martoni CJ, Ganopolsky JG, Labbe A, and <strong>Prakash*</strong>S (2014). The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention. Expert Opinion Biological Therapy 2014. http://dx.doi.org/10.1016/j.addr.2014.01.004</p>
							</li>
							<li>
								<p class="auto-style7">Paul A, Hasan A, Rodes L, Sangaralingam M, and  <strong>Prakash*</strong> S (2014). Bioengineered baculoviruses as new class of therapeutics using micro and nanotechnologies: Principles, prospects and challenges. Advance Drug Delivery Review. 3 February 2014, http://dx.doi.org/10.1016/j.addr.2014.01.004</p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash*</strong>S, Tomaro-Duchesneau C, Saha S, Rodes L, Kahouli I, Malhotra M (2014). Probiotics for the prevention and treatment of allergies, with an emphasis on mode of delivery and mechanism of action. current Pharmaceutical Deisgn. Vol. 20. 2014:20(6):10254-37.</p>
							</li>
							<li>
								<p class="auto-style7">Marinescu D, Tomaro-Duchesneau C, Malhotra M, Kahouli I, Jones M. L, Rodes L,  <strong>Prakash*</strong> S (2014). Effect of orally administered APA microencapsulated BSH-active Lactobacillus reuteri NCIMB 30242 on markers of obesity: an in-vivo analysis. Journal of Medical Microbiology. J Microbiol Biotechnol. 2013 Apr; 23(4):518-26.</p>
							</li>
							<li>
								<p class="auto-style7">Tomaro-Duchesneau C, Saha S, Malhotra M, Rodes L, and  <strong>Prakash*</strong>S (2014). Effect of orally administered L. fermentum NCIMB 5221 on markers of metabolic syndrome: an in vivo analysis using ZDF rats. Applied Microbiology and Biotechnology. Vol. 98, 1:115-126.</p>
							</li>
							<li>
								<p class="auto-style7">Paul A, Srivastava S, Chen G, Shum-Tim D,  <strong>Prakash*</strong>, S. (2013).Functional Assessment of Adipose Stem Cells for Xenotransplantation Using Myocardial Infarction Immunocompetent Models: Comparison with Bone Marrow Stem Cells. Cell Biochemistry and Biophysics. Dec 29.PMID: 22205499. Funding CIHR MOP 64308 and NSERC discovery.</p>
							</li>
							<li>
								<p class="auto-style7">Malhotra M, Tomaro-Duchesneau C, Saha S, and <strong>Prakash*</strong> S. (2013) Systemic siRNA Delivery via Peptide-Tagged Polymeric Nanoparticles, Targeting PLK1 Gene in a Mouse Xenograft Model of Colorectal Cancer. International Journal Biomaterials. 2013; 252531. Sep 15.PMID: 24159333. Funding MOP 86722.</p>
							</li>
							<li>
								<p class="auto-style7">Malhotra M, Tomaro-Duchesneau C, Saha S and <strong>Prakash*</strong> S (2013). Intranasal siRNA delivery to the brain by TAT/MGF tagged PEGylated chitosan nanoparticles. Journal of Pharmaceutics. Vol. 2013, Article ID: 812387,10 pages.</p>
							</li>
							<li>
								<p class="auto-style7">Rodes L, Tomaro-Duchesneau C, Saha S, Paul A, Malhotra M, Marinescu D, Shao W, Kahouli I, and  <strong>Prakash*</strong> S (2013). Enrichment of Bifidobacterium longum subsp. infantis ATCC 15697 within the human gut microbiota using alginate-poly- l-lysine- alginate microencapsulation oral delivery system: an in vitro analysis using a computer-controlled dynamic human gastrointestinal model. Journal of Microencapsulation. 2013</p>
							</li>
							<li>
								<p class="auto-style7">Tomaro-Duchesneau C, Saha S, Malhotra M, Jones ML, Labbé A, Rodes L, Kahouli I, and  <strong>Prakash*</strong> S. (2013). Effect of orally administered L. fermentum NCIMB 5221 on markers of metabolic syndrome: an in vivo analysis using ZDF rats. Funding: MOP 64308.</p>
							</li>
							<li>
								<p class="auto-style7">Jones, M.L., Martoni,C.J., Ganoplsky, J.,G., Sulemankhil, I, Ghali, P; and  <strong>Prakash*</strong>, S. (2013). Improvement of gastrointestinal health status in subjects consuming Lactobacillus reuteri NCIMB 30242 capsules: a post-hoc analysis of a randomized controlled trial. Expert Opinion On Biological Therapy. 2013 Sep 28. PMID: 24074303. Funding: Micropharma</p>
							</li>
							<li>
								<p class="auto-style7">Shao W, Paul A, Zhao B, Lee C, Rodes L, <strong>Prakash*</strong> S. (2013) Carbon nanotube lipid drug approach for targeted delivery of a chemotherapy drug in a human breast cancer xenograft animal model. Biomaterials. 2013 Dec; 34(38):10109-19. PMID: 24060420: Funding MOP 86722.</p>
							</li>
							<li>
								<p class="auto-style7">Sinno H,  <strong>Prakash*</strong> S (2013) Complements and the wound healing cascade: an updated review. Plastic Surgery Int. 2013; 2013:146764; Funding: RV Foundation</p>
							</li>
							<li>
								<p class="auto-style7">Paul,A., Elias,C.B., Shum-Tim,D., &amp; <strong>Prakash*</strong>,S (2013).Bioactive baculovirus nanohybrids for stent based rapid vascular re-endothelialisation. Nature Sci. Rep. 3, 2366 (2013). Funding: MOP: 93641.</p>
							</li>
							<li>
								<p class="auto-style7">Le Huu A, Paul A, Xu L,  <strong>Prakash</strong> S, Shum-Tim D (2013). Recent advancements in tissue engineering for stem cell-based cardiac therapies. Therapeutic Delivery. 2013 Apr; 4(4):503-16. PMID: 23557290. Funding: MOP: 93641.</p>
							</li>
							<li>
								<p class="auto-style7">Paul A, Shum-Tim D,  <strong>Prakash*</strong> S (2013). Angiogenic nanodelivery systems for myocardial therapy. Methods Molecular Biology. 2013;1036:137-49. PMID: 23807793; Funding: MOP 86722, NSERC.</p>
							</li>
							<li>
								<p class="auto-style7">Huu AL, Paul A,  <strong>Prakash</strong> S, Shum-Tim D (2013). Route of delivery, cell retention, and efficiency of polymeric microcapsules in cellular cardiomyoplasty. Methods Molecular Biology. 2013;1036:121-35. PMID: 23807792; Funding: MOP 86722, NSERC.</p>
							</li>
							<li>
								<p class="auto-style7">Sinno H, Malhotra M, Lutfy J, Jardin B, Winocour S, Brimo F, Beckman L, Watters K, Philip A, Williams B, <strong>Prakash*</strong> S (2013) Complements c3 and c5 individually and in combination increase early wound strength in a rat model of experimental wound healing. Plastic Surgery International 2013; 2013:243853. PMID:23807792. Funding: MOP 64308</p>
							</li>
							<li>
								<p class="auto-style7">Rodes L, Coussa-Charley M, Marinescu D, Paul A, Fakhoury M, Abbasi S,  <strong>Prakash*</strong>, S (2013). Effect of probiotics Lactobacillus and Bifidobacterium on gut-derived lipopolysaccharides and inflammatory cytokines: an in vitro study using a human colonic microbiota model. Journal of Microbiol Biotechnol. Apr; 23(4):518-526. PMID: 23568206. Funding: MOP 64308.</p>
							</li>
							<li>
								<p class="auto-style7">Rodes,L, Tomaro-Duchesneau,C, Saha,S, Paul,A, Malhotra,M, Marinescu,D, Shao,W, Kahouli,I,  <strong>Prakash*</strong>,S: Enrichment of Bifidobacterium longum subsp. infantis ATCC 15697 within the human gut microbiota using alginate-poly- l-lysine- alginate microencapsulation oral delivery system: an in vitro analysis using a computer-controlled dynamic human gastrointestinal model. J Microencapsul 2013.</p>
							</li>
							<li>
								<p class="auto-style7">Malhotra, M., Tomaro-Duchesneau,C., Saha S, Kahouli I and  <strong>Prakash*</strong>,S (2013). Development and characterization of chitosan-PEG- TAT nanoparticles for the intracellular delivery of siRNA. International Journal of Nanomedicine. 2013;8:2041-52 PMID:23723699. Funding NSERC discovery.</p>
							</li>
							<li>
								<p class="auto-style7">Saha, S., Tomaro-Duchesneau,C., Tabrizian,M., and <strong>Prakash*</strong>,S. (2013) Novel probiotic dissolvable carboxymethyl cellulose films as oral health biotherapeutics: in vitro preparation and characterization. Expert Opinion Drug Delivery. 2013 May 29. [Epub ahead of print] PMID:23713443. Funding MOP: 64308</p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash*</strong> S, Tomaro-Duchesneau C, Saha S, Rodes L, Kahouli I, Malhotra M (2013). Probiotics For The Prevention And Treatment Of Allergies, With An Emphasis On Mode Of Delivery And Mechanism Of Action. Current Pharmaceutic Design. 2013 May 17 PMID:23701572: Funding: MOP 64308.</p>
							</li>
							<li>
								<p class="auto-style7">Jones,M.L., Martoni,C.J., and  <strong>Prakash*</strong>,S (2013).Oral Supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-Hydroxyvitamin D: A post hoc analysis of a randomized controlled trial. Journal of Clinical Endocrinology Metaboloism. 2013 Jul; 98(7):2944-51. Apr 22. PMID: 23609838. Funding: Micopharma</p>
							</li>
							<li>
								<p class="auto-style7">Rodes L, Coussa-Charley M, Marinescu D, Paul A, Fakhoury M, Abbasi S, and  <strong>Prakash*</strong>, S (2013). Effect of probiotics Lactobacillus and Bifidobacterium on gut-derived lipopolysaccharides and inflammatory cytokines: an in vitro study using a human colonic microbiota model. Journal of Microbiol Biotechnol. Apr;23(4):518-526. PMID: 23568206.</p>
							</li>
							<li>
								<p class="auto-style7">Kahouli I, Tomaro-Duchesneau C, and  <strong>Prakash*</strong> S (2013). Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives. Journal of Medical Microbiology Aug; 62(Pt 8):1107-23. PMID:23558140. Funding: MOP 64308.</p>
							</li>
							<li>
								<p class="auto-style7">Rodes L, Coussa-Charley M, Marinescu D, Paul A, Fakhoury M, Abbasi S, and  <strong>Prakash*</strong>, S (2013). Design of a novel gut bacterial adhesion model for probiotic applications. Artificial Cells, Nanomedicine, and Biotechnology, 2013; 41: 116&#8211;124Apr;41(2):116-24. PMID:22889228; Funding: MOP :64308</p>
							</li>
							<li>
								<p class="auto-style7">Jasmine Bhathena, Christopher Martoni, Arun  Kulamarva, Catherine Tomaro-Duchesneau, Meenakshi Malhotra, Arghya Paul, Aleksandra Malgorzata Urbanska, and  <strong>Prakash*</strong>,S (2013) Oral Probiotic Microcapsule Formulation Ameliorates Non-Alcoholic Fatty Liver Disease in Bio F1B Golden Syrian Hamsters. PLoS ONE 8(3). PMID: 23554890. Funding: NSERC discovery, Micropharma Grant # 205811.</p>
							</li>
							<li>
								<p class="auto-style7">Malhotra,M., Tomaro-Duchesneau,C., and <strong>Prakash*</strong>,S (2013). Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases. Biomaterials 34, 1270-1280 (2013). Funding: NSERC discovery.</p>
							</li>
							<li>
								<p class="auto-style7">Tomaro-Duchesneau  C, Saha S, Malhotra M, Kahouli I and  <strong>Prakash*</strong> S. Microencapsulation for the  therapeutic delivery of drugs, live mammalian and bacterial cells and other  biopharmaceutics: current status and future directions. Journal of  Pharmaceutics (In press) Submission ID: 103527. </p>
							</li>
							<li>
								<p class="auto-style7">Marinescu  D, Tomaro-Duchesneau C, Malhotra M, Kahouli I, Jones M. L, Rodes L, <strong>Prakash*</strong> S.  Effect of orally administered APA microencapsulated BSH-active Lactobacillus  reuteri NCIMB 30242 on markers of obesity: an in-vivo analysis. Journal of  Medical Microbiology. (Accepted) Submission ID: JMM/2012/048298</p>
							</li>
							<li>
								<p class="auto-style7">Saha S, Tomaro-Duchesneau C, Malhotra M, Tabrizian M and <strong>Prakash*</strong>S. Suppression of Streptococcus mutans and Candida albicans by probiotics: an in vitro study. Dentistry. Vol. 2, 6:1-8. </p>
							</li>
							<li>
								<p class="auto-style7">Tomaro-Duchesneau C, Saha S,   Malhotra M, Coussa-Charley M,  Al-Salami H, Kahouli I,  Jones ML, Labb&eacute; A, <strong>Prakash*</strong> S. Probiotic Ferulic Acid  Esterase Active Lactobacillus fermentum NCIMB 5221 Cells APA Microcapsules for  Oral Delivery: Preparation and In Vitro Characterization. Pharmaceuticals. 2012; 5(2): 236-248.</p>
							</li>
							<li>
								<p class="auto-style7">Saha S,  Tomaro-Duchesneau C, Tabrizian M, <strong>Prakash*</strong>S. Probiotics as oral health  biotherapeutics.Expert Opin Biol Ther. 2012; 12(9):1207-20.</p>
							</li>
							<li>
								<p class="auto-style7">Tomaro-Duchesneau C,  Saha S,   Malhotra M,  Coussa-Charley M, Al-Salami H,  Jones ML,   Labb&eacute; A, <strong>Prakash*</strong>> S. Lactobacillus fermentum NCIMB 5221 has a  greater potential for the production of ferulic acid when compared to other  ferulic acid esterase active Lactobacilli. International Journal of Probiotics  and Prebiotics. 2012; 7(1):23-32.</p>
							</li>
							<li>
								<p class="auto-style7">Bhathena  J*, Tomaro-Duchesneau C*, Martoni C, Malhotra M, Kulamarva A, Urbanska AM, Paul  A and  <strong>Prakash*</strong> S. Effects of orally administered microencapsulated  FA-producing L. fermentum on markers of metabolic syndrome: an in vivo  analysis. Journal of Diabetes and Metabolism. 2012; S2-009.</p>
							</li>
							<li>
								<p class="auto-style7">Sinno H, Malhotra  M, Lutfy J, Jardin BA, Winocour S, Brimo F, Beckman L, Watters K, Philips A,  Williams B and <strong>Prakash*</strong> S. The effects of topical collagen treatment on  wound strength and scar cosmesis in rats. The Canadian Journal of Plastic  Surgery 2012;20, 3:181-185.</p>
							</li>
							<li>
								<p class="auto-style7">Sinno H, Malhotra  M, Lutfy J, Jardin BA, Winocour S, Brimo F, Beckman L, Watters K, Philips A,  Williams B and <strong>Prakash*</strong>S. Accelerated Wound Healing with Topical  Application of Complement C5. Plastic and Reconstructive Surgery journal. 2012;130, 3:523-529.</p>
							</li>
							<li>
								<p class="auto-style7">Shao W, Paul A, Abbasi S, Chahal PS,  Mena JA, Montes J,  Kamen A, <strong>Prakash*</strong> S. A novel  polyethyleneimine-coated adeno-associated virus-like particle formulation for  efficient siRNA delivery in breast cancer therapy: preparation and in vitro  analysis. Int. J of Nanomedicine. 2012; 1575 &ndash; 1586</p>
							</li>
							<li>
								<p class="auto-style7">Paul A , Shao W ,  Shum-Tim D , <strong>Prakash*</strong> S . The attenuation of restenosis following arterial gene  transfer using carbon nanotube coated stent incorporating TAT/DNA(Ang1+Vegf)  nanoparticles. Biomaterials 2012; 33(30):7655-64.</p>
							</li>
							<li>
								<p class="auto-style7">Afkhami F, Durocher Y, <strong>Prakash*</strong> S.  Microencapsulated mammalian cells for simultaneous production of VEGF165b and  IFN&alpha;. Artif Cells Blood Substit Immobil Biotechnol. 2012;40(1-2):1-6.</p>
							</li>
							<li>
								<p class="auto-style7">Sulemankhil I ,  Parent M , Jones ML , Feng Z , Labb&eacute; A, <strong>Prakash*</strong> S. In vitro and  in vivo characterization and strain safety of Lactobacillus reuteri NCIMB 30253  for probiotic applications Canadian journal of microbiology. 2012; 58(6): 776-87. </p>
							</li>
							<li>
								<p class="auto-style7">Jones ML, Martoni  CJ, Tamber S, Parent M,  <strong>Prakash*</strong> S (2012) Evaluation of safety and tolerance of  microencapsulated Lactobacillus reuteri NCIMB 30242 in a yogurt formulation: a  randomized, placebo-controlled, double-blind study. Food Chem. Toxicol. 2012;50(6):2216-23.</p>
							</li>
							<li>
								<p class="auto-style7">Coussa RG, Shah S,  Jain P, Martoni C, Bhathena J, Malhotra M, <strong>Prakash*</strong> S. Microencapsulated  Saccharomyces cerevisiae column bioreactor for potential use in renal failure  uremia. Artif Cells Blood Substit Immobil Biotechnol. 2012;40(1-2):103-12.</p>
							</li>
							<li>
								<p class="auto-style7">Le Huu A ,  <strong>Prakash</strong> S  , Shum-Tim D. Cellular cardiomyoplasty: current state of the field.  Regenerative medicine. 2012; 7(4): 571-82.</p>
							</li>
							<li>
								<p class="auto-style7">Abbasi S , Paul A ,  Shao W ,<strong>Prakash*</strong>strong> S. Cationic albumin nanoparticles for enhanced drug  delivery to treat breast cancer: preparation and in vitro assessment. Journal  of drug delivery.2012 Article ID686108, 8 pages</p>
							</li>
							<li>
								<p class="auto-style7">Jones ML , Martoni  CJ , Di Pietro E , Simon RR , <strong>Prakash*</strong> S. Evaluation of clinical safety  and tolerance of a Lactobacillus reuteri NCIMB 30242 supplement capsule: A  randomized control trial. Regulatory toxicology and pharmacology: RTP . 2012; 63(2):  313-20.</p>
							</li>
							<li>
								<p class="auto-style7">Jardin BA , Elias CB  , <strong>Prakash*</strong> S. Expression of a secreted protein in mammalian cells using  baculovirus particles. Methods in molecular biology, 2012; 801: 41-63.</p>
							</li>
							<li>
								<p class="auto-style7">Jones M , Ganopolsky  JG , Labb&eacute; A , Gilardino M , Wahl C , Martoni C, <strong>Prakash*</strong> S. Novel  nitric oxide producing probiotic wound healing patch: preparation and in vivo  analysis in a New Zealand white rabbit model of ischaemic and infected wounds.  International wound journal. 2012;9(3): 330-4</p>
							</li>
							<li>
								<p class="auto-style7">Jones ML, Martoni  CJ, Parent M,<strong>Prakash*</strong> S.Cholesterol-lowering efficacy of a  microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242  yoghurt formulation in hypercholesterolaemic adults. Br J Nutr. 2012;107(10):1505-13. </p>
							</li>
							<li>
								<p class="auto-style7">Paul A, Chen G, Khan A A, Rao V, Shum-Tim D, <strong>Prakash*</strong> S .Genipin-crosslinked microencapsulated human adipose stem cells augment transplant retention resulting in attenuation of chronically infarcted rat heart fibrosis and cardiac dysfunction. Cell Transplantation 2012. Apr 10.</p>
							</li>
							<li>
								<p class="auto-style7">Paul A, Nayan M, Khan AA, Shum-Tim D, <strong>Prakash*</strong> S.  Angiopoietin-1-expressing adipose stem cells genetically modified with  baculovirus nanocomplex: investigation in rat heart with acute infarction. Int J Nanomedicine. 2012; 7:663-82.</p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash*</strong> S,  Malhotra M, Shao W,   Tomaro-Duchesneau C,  Abassi S. Polymeric nanohybrids and  functionalized carbon nanotubes as drug delivery carriers for cancer therapy.  Advanced Drug Delivery Reviews. 2011;63(14-15):1340-51.</p>
							</li>
							<li>
								<p class="auto-style7">Paul A, Srivastava S, Chen G, Shum-Tim D,  <strong>Prakash*</strong> S. Functional Assessment of Adipose Stem Cells for Xenotransplantation  Using Myocardial Infarction Immunocompetent Models: Comparison with Bone Marrow Stem Cells.Cell Biochem Biophys. 2011 Dec 29. [Epub ahead of print]</p>
							</li>
							<li>
								<p class="auto-style7">Rodes L, Paul A, Coussa-Charley M, Al-Salami H, Tomaro-Duchesneau C, Fakhoury M, <strong>Prakash*</strong> S. Transit time affects the  community stability of lactobacillus and bifidobacterium species in an in vitro model of human colonic microbiotia. Artif Cells Blood Substit  Immobil Biotechnol. 2011 Dec; 39(6):351-6</p>
							</li>
							<li>
								<p class="auto-style7">Paul A, Binsalamah ZM, Khan AA, Abbasia S, Elias CB, Shum-Tim D, and <strong>Prakash*</strong> S. A nanobiohybrid complex of recombinant  baculovirus and Tat/DNA nanoparticles for delivery of Ang-1 transgene in myocardial infarction therapy. Biomaterials. 2011 Nov;32(32):8304-18. 2011 Aug 15.</p>
							</li>
							<li>
								<p class="auto-style7"><strong>Prakash*</strong> S, Rodes L, Coussa-Charley M, and Tomaro-Duchesneau  C. Gut microbiota: next frontier in understanding human health and development  of biotherapeutics. Biologics. 2011;5:71-86. 2011 Jul 11.</p>
							</li>
							<li>
								<p class="auto-style7">Nayan M, Paul A, Chen G, Chiu RC, <strong>Prakash*</strong> S, and Shum-Tim D. Superior therapeutic potential of young bone marrow mesenchymal  stem cells by direct intramyocardial delivery in aged recipients with  acute myocardial infarction: in vitro and in vivo investigation. J Tissue Eng. 2011; 2011:741213. 2011 Jul 24.</p>
							</li>
							<li>
								<p class="auto-style7"><strong>Prakash*</strong> S, Tomaro-Duchesneau C, Saha S, Cantor A. The gut microbiota and human health with an emphasis on the use of microencapsulated  bacterial cells. J Biomed Biotechnol. 2011;2011:981214. 2011 Jul 2.</p>
							</li>
							<li>
								<p class="auto-style7">Bhathena J, Kulamarva A, Martoni C, Malgorzata A, Malhotra UM, Paul A, <strong>Prakash*</strong> S. Diet-induced metabolic hamster model of nonalcoholic fatty liver disease. Diabetes Metab Syndr Obes. 2011;4:195-203. 2011 Jun 3.</p>
							</li>
							<li>
								<p class="auto-style7">Burdon T, Paul A, Noiseux N, <strong>Prakash</strong> S, and Dominique*  S. Bone Marrow Stem Cell Derived Paracrine Factors for Regenerative  Medicine: Current Perspectives and Therapeutic Potential. Bone Marrow  Research, 2011, Article ID 207326, doi:10.1155/2011/207326</p>
							</li>
							<li>
								<p class="auto-style7">Malhotra M, Lane C, Tomaro-Duchesneau C, Saha S and <strong>Prakash*</strong> S . A novel scheme for synthesis of PEG-grafted-chitosan polymer for preparation of nanoparticles and other applications. International Journal of Nanomedicine. 2011; Vol. 2011, 6: 485-494.</p>
							</li>
							<li>
								<p class="auto-style7">Malhotra M, Nambiar S, Rengaswamy V and <strong>Prakash*</strong> S. siRNA design strategies for effective targeting and gene silencing. Expert Opinion on Drug Discovery. 2011; Vol. 6, 3: 269-289</p>
							</li>
							<li>
								<p class="auto-style7">Malhotra M and <strong>Prakash*</strong> S. Cell penetrating peptides based nanoparticles for targeted delivery of therapeutic molecules across blood brain barrier: potential and limitations. Current Nanosciences. 2011; Vol. 7, 1: 81-93.</p>
							</li>
							<li>
								<p class="auto-style7">Al-Kindi AH, Asenjo JF, Ge Y, Chen GY, Bhathena J, Chiu RC,<strong>Prakash</strong>S, Shum-Tim D*.Microencapsulation to reduce mechanical loss of microspheres: implications in myocardial cell therapy. Surgery. 2011; Vol. 39: 241-247</p>
							</li>
							<li>
								<p class="auto-style7">Apte SS, Paul A,<strong>Prakash</strong> S, Shum-Tim D*. Current developments in the tissue engineering of autologous heart valves: moving towards clinical use. Future Cardiology. 2011; Vol. 7(1) 77-97</p>
							</li>
							<li>
								<p class="auto-style7">Branton, W. B., Jones, M. L., Tomaro-Duchesneau, C., Martoni, C. J., <strong>Prakash*</strong> S. In-vitro characterization and safety of the probiotic strain Lactobacillus reuteri cardioviva NCIMB 30242. International journal of probiotics and prebiotics. 2011</p>
							</li>
							<li>
								<p class="auto-style7">Khan A, A Paul*, Abbasi S*,<strong>Prakash*</strong> S. Mitotic and antiapoptotic effects of nanoparticles co-encapsulating hVEGF and hAng-1 can induce on vascular endothelial cells. International Journal of Nanomedicine, 2011</p>
							</li>
							<li>
								<p class="auto-style7">Paul A, Shum-Tim D, <strong>Prakash*</strong>  S.Investigation on PEG Integrated Alginate Chitosan Microcapsules for Myocardial Therapy Using Marrow Stem Cells Genetically Modified by Recombinant Baculovirus. Cardiovascular Engineering and Technology. 2010; Vol 1(2): 154-164. </p>
							</li>
							<li>
								<p class="auto-style7">Paul A, Khan A, Shum-Tim D, <strong>Prakash*</strong> S. BacMam virus transduced cardiomyoblasts can be used for myocardial transplantation using AP-PEG-A microcapsules: molecular cloning, preparation and in vitro analysis. Journal of Biomedicine and Biotechnology Vol. 1-12,2010</p>
							</li>
							<li>
								<p class="auto-style7">Paul A, Jardin BA, Kulamarva A, Malhotra M, Elias CB, <strong>Prakash*</strong> S.Recombinant baculovirus as a highly potent vector for gene therapy of human colorectal carcinoma: molecular cloning, expression, and in vitro characterization.Mol Biotechnol. 2010; Vol. 45(2):129-39</p>
							</li>
							<li>
								<p class="auto-style7">Paul A, ElHayek E, Shum-Tim D, <strong>Prakash*</strong> S. Recent Advancements in Pharmacological Stent Therapy using Polymeric Materials: Opportunities and Challenges. Current Drug Delivery journal. 2010; Vol 7(3):216-224</p>
							</li>
							<li>
								<p class="auto-style7">Paul A, Abbasi S, Shum-Tim D, <strong>Prakash*</strong>  S. Nano-bioengineering approaches in current and future generation of cardiovascular stents. Current Nanoscience. 2010; Vol. 6(5):469-478.</p>
							</li>
							<li>
								<p class="auto-style7">Urbanska A, Paul A, Bhathena J,<strong>Prakash*</strong> S. Suppression of Tumorigenesis: Modulation of Inflammatory Cytokines by Oral Administration of Microencapsulated Probiotic Yogurt Formulation. International Journal  of Inflammation. 2010; Vol 2010, Article ID 894972, doi:10.4061/2010/894972.</p>
							</li>
							<li>
								<p class="auto-style7">Paul A and <strong>Prakash*</strong> S. Baculovirus reveals a new pH-dependent direct cell-fusion pathway for cell entry and transgene delivery. Future Virology. 2010; Vol. 5(5): 533-537.</p>
							</li>
							<li>
								<p class="auto-style7"><strong>Prakash*</strong> S, Khan A and Paul A. Nanoscaffold based stem cell regeneration therapy: recent advancement and future potential. Expert Opin Biol Ther. 2010; Vol. 10(12):1649-61.</p>
							</li>
							<li>
								<p class="auto-style7">Paul A, Cantor A, Shum-Tim D, <strong>Prakash*</strong> S. Superior stem cell delivery features of genipin crosslinked polymeric microcapsules: preparation and in vitro characterization using human adipose stem cells. Molecular Biotechnology. 2010 </p>
							</li>
							<li>
								<p class="auto-style7">Chen H, Ouyang W, Martoni C, Afkhami F, Lawuyi B, Lim T and <strong>Prakash*</strong> S.  Investigation of genipin cross-linked microcapsule for oral delivery of live bacterial cell and other biotherapeutics: preparation and in-vitro  analysis in simulated human gastrointestinal model. International Journal of Polymer Science. 2010; Vol 2010</p>
							</li>
							<li>
								<p class="auto-style7">Afkhami F, Durocher Y and <strong>Prakash*</strong> S. Investigation of anti-angiogenic tumor therapy potential of microencapsulated HEK293 VEGF165b producing cells. Journal of Biomedicine and Biotechnology. 2010</p>
							</li>
							<li>
								<p class="auto-style7">Sebak S, Mirzaei M, Malhotra M, Kulamarva A, and <strong>Prakash*</strong> S. Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis. Int. J. Nanomedicine. 2010; Vol. 2010(5): 525-532.</p>
							</li>
							<li>
								<p class="auto-style7">Coussa R, Martoni C, Bhathena C, Urbanska AM and <strong>Prakash*</strong> S. Oral Microencapsulated Live Saccharomyces Cerevisiae Cells for Use in   Renal Failure Uremia: Preparation and in-Vivo Analysis, Journal of Biomedicine and Biotechnol. 2010</p>
							</li>
							<li>
								<p class="auto-style7">Jones, M. L., Ganopolsky JG, Labbe A, Wahl C, and <strong>Prakash</strong> S. Antimicrobial properties of nitric oxide and its application in antimicrobial formulations and medical devices. Applied Microbiology and Biotechnology. 2010; Vol. 88(2): 401-407.</p>
							</li>
							<li>
								<p class="auto-style7">Jones M, Ganopolsky JG, Labbe A, and <strong>Prakash*</strong> S. Novel nitric oxide producing probiotic wound healing patch and its antimicrobial  efficacy: preparation and in vitro analysis. Applied Microbial Biotechnology. 2010; Vol. 87(2):509-16.</p>
							</li>
							<li>
								<p class="auto-style7">Singh P, Kumar P, Katyal A, Kalra R, Dass SK, <strong>Prakash</strong> S, Chandra R. Synthesis and electrochemical studies of charge-transfer complexes of thiazolidine-2,4-dione with sigma and pi acceptors. Spectrochim Acta A Mol Biomol Spectrosc. 2010. 75(3):983-91.</p>
							</li>
							<li>
								<p class="auto-style7">Paul A, Ge Y,  <strong>Prakash*</strong> S, Shum-Tim  D.Microencapsulated stem cells for tissue repairing: implications in cell-based myocardial therapy. Regen Med. 2009 Sep;4(5):733-45.</p>
							</li>
							<li>
								<p class="auto-style7">Malhotra M, Kulamarva A,  Sebak S, Paul A, Bhathena J, Mirzaei M, <strong>Prakash*</strong>  S (2009). Ultra-small nanoparticles of low molecular weight Chitosan as an efficient delivery system targeting neuronal cells. Drug Development and Industrial Pharmacy. Vol. 35, 6:719-726.</p>
							</li>
							<li>
								<p class="auto-style7"> Bhathena J, Martoni C, Kulamarva A, Urbanska A, Malhotra M and <strong>Prakash*</strong> S (2009). Orally delivered microencapsulated live probiotic formulation lowers serum lipids in hypercholesterolemic hamsters. Journal of Medicinal Food. Vol. 12, 2:310-9</p>
							</li>
							<li>
								<p class="auto-style7">Arun Kulamarva , Pavan Raja, Jasmine Bhathena, Hongmei Chen, Saikat  Talapatra, Pulickel Ajayan, Omkaram Nalamasu and Satya <strong>Prakash</strong> (2009). Microcapsule carbon nanotube devices for therapeutic applications. Nanotechnology. Vol. 20 (2) 025612 (7pp)</p>
							</li>
							<li>
								<p class="auto-style7">Arun Kulamarva, Jasmine Bhathena, Meenakshi Malhotra, Safaa Sebak, Pulicke Ajayan and Satya <strong>Prakash*</strong> (February 2008). In-vitro cytotoxicity of functionalized single walled carbon nanotubes for targeted gene delivery applications. Nanotoxicology (in press).</p>
							</li>
							<li>
								<p class="auto-style7">Maryam Mirzaei, Barabara Jardin, Cynthia Elias and Satya <strong>Prakash*</strong>, (2008). Non-viral production of human Interleukin-7 in Spodoptera frugiperda insect cells as a soluble recombinant protein. Journal of Biomedicine and Biotechnology. (in press). Funding: NSERC 239094.</p>
							</li>
							<li>
								<p class="auto-style7">Christopher Martoni, Jasmine Bhathena, Mitchell Lawrence Jones, Aleksandra Urbanska, Hongmei Chen, and Satya<strong>Prakash*</strong> (2008). Preparation and in-vitro analysis of microencapsulated genetically engineered Lactobacillus Plantarum 80 BSH overproducing cells for oral delivery as a cholesterol lowering therapy. Journal of Biotechnology (in press).</p>
							</li>
							<li>
								<p class="auto-style7">Hongmei Chen, Wei Ouyang, Jasmine Bhathena, Christopher Martoni, and Satya <strong>Prakash*</strong>(2008). Investigation of microcapsules for potential oral applications using a dynamic simulated human gastrointestinal model. Letters in Drug Delivery (in press).</p>
							</li>
							<li>
								<p class="auto-style7">Aleksandra Urbanska, Jasmine Bhathena, Arun Kulamarva, Christopher Martoni, and Satya <strong>Prakash*</strong> (2008). Estimation of the potential antitumor activity of microencapsulated Lactobacillus acidophilus yogurt formulation in the progression of colon cancer in Apc(Min/+) mice. Digestive Diseases and Sciences, Jul 17.</p>
							</li>
							<li>
								<p class="auto-style7">Maryam Mirzaei, Barbara Jardin, Cynthia B. Elias, and Satya <strong>Prakash*</strong>(2008). Expression and production of human Interleukin-7 in insect cells using Baculovirus Expression Vector System (BEVS). Applied Biochemistry and Biotechnology June 11 </p>
							</li>
							<li>
								<p class="auto-style7">Christopher Martoni, Jasmine Bhathena, Mitchell Lawrence Jones, Aleksandra Urbanska, Hongmei Chen, and Satya <strong>Prakash*</strong>(2008). Microencapsulated bile salt hydrolase producing L. reuteri for oral targeted delivery in the gastrointestinal tract. Applied Microbiology and Biotechnology Aug 22. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash*</strong> S, Malhotra M, (2008). Recent advancements in targeted delivery of therapeutic molecules in neurodegenerative disease - spinocerebellar ataxia - opportunities and challenges. Drug Target Insights, 3, pp 99-117 </p>
							</li>
							<li>
								<p class="auto-style7">Satya <strong>Prakash*</strong> and Aleksandra Urbanska . (2008). Feasibility and efficacy in delivery of live probiotic bacterial cells: gastrointestinal diseases with emphasis on colonic targeting, Biologics: Targets &amp; Therapy, 2(3), 355&ndash;378.</p>
							</li>
							<li>
								<p class="auto-style7">Barbara Jardin, Zhao Y, Sivraj M., Motes, J., Trans R,<strong>Prakash*</strong> Satya and Elias CB * (2008). Expression of SEAP (secreted alkaline phosphatase) by baculovirus mediated transduction of HEK293 cells in a hollow fiber bioreactor system. Journal of Biotechnology. Jun 30; 135( 3): 272-80, Funding: NSERC 239094.</p>
							</li>
							<li>
								<p class="auto-style7">Satya <strong>Prakash*</strong>and Jasmine Bhathena (2008). Live immobilized cells as new therapeutics . Journal of Drug Delivery Science and Technology Vol. 1 8(1): 3-14.</p>
							</li>
							<li>
								<p class="auto-style7">Bhathena J., Kulamarva A. Urbanska Aleksandra Malgorzata, Martoni Christopher, and <strong>Prakash*</strong> S. (2008).Preparation and  11976 for augmentation of feruloyl esterase in the gastrointestinal intestinal tract. Biotechnology and Applied Biochemistry . Jul 20. vol. 75, no. 5, pp. 1023&ndash;1029.</p>
							</li>
							<li>
								<p class="auto-style7">Urbanska A. M., Bhathena J., and <strong>Prakash*</strong>Satya (2007). Live encapsulated Lactobacillus acidophilus cells in yogurts for therapeutic oral delivery: preparation and in-vitro analysis of alginate-chitosan microcapsules. Canadian Journal of Physiology and Pharmacology. Sep; 85 ( 9): 884-93.</p>
							</li>
							<li>
								<p class="auto-style7">Bisi Lawuyi, Hongmei Chen, Fatemeh Afkhami, Arun Kulamarva, Satya <strong>Prakash*</strong> (2007) Microencapsulation of engineered Lactococcus lactis in alginate-poly-l-lysine-alginate capsules for heterologous protein delivery. Applied Biochemistry and Biotechnology. 142, 1, 71-80.</p>
							</li>
							<li>
								<p class="auto-style7">AlKindi, A., Chen, G., Ge, Y., Bhathena, J., Chiu, R., <strong>Prakash*</strong>,  S., Shum-Tim, D. (2007) Microencapsulated stem cell retention for localized cardiac cell delivery. Canadian Journal of Cardiology; Vol. 23:77C. </p>
							</li>							
							<li>
								<p class="auto-style7">Martoni C, Bhathena J, Jones ML, Urbanska AM, Chen H, <strong>Prakash*</strong> S. (2007). Investigation of Microencapsulated BSH Active Lactobacillus in the Simulated Human GI Tract. Journal of Biomedicine and Biotechnology. ( 7): 13684.</p>
							</li>
							<li>
								<p class="auto-style7">Satya <strong>Prakash*</strong> and Arun Kulamarva (2007). Recent advances in drug delivery: Potential and Limitations of Carbon Nanotubes Recent patents in drug delivery and formulations. Bentham Publications, USA. Pp. 214-221.</p>
							</li>
							<li>
								<p class="auto-style7">Bhathena J., Kulamarva A. Urbanska Aleksandra Malgorzata, Christopher Martoni, and <strong>Prakash*</strong> S. (2007). Microencapsulated bacterial cells can be used to produce the enzyme feruloyl esterase: Preparation and in-vitro analysis. Applied Microbiology and Biotechnology,  Jul; 75(5):1023-1029. </p>
							</li>
							<li>
								<p class="auto-style7">Aleksandra Malgorzata Urbanska, Jasmine Bhathena, and Satya <strong>Prakash*</strong> (2007). Live encapsulated Lactobacillus acidophilus cells in yogurts for therapeutic oral delivery: preparation and in-vitro analysis of alginate-chitosan microcapsules. International Journal of Prebiotics and Probiotics. 3, Aug. 225-229. </p>
							</li>
							<li>
								<p class="auto-style7">Al-Kindi, A., Chen, G., Asenjo, J.F., Ge, Y., Bhathena, J., Chiu, R, <strong>Prakash</strong>, S., Shum-Tim, D. (2007) Circulation; Vol. 116(16):591-592. </span></p>
							</li>
							<li>
								<p class="auto-style7">Manisha Tiwari and Ramesh Chandra Sujata K. Das and Satya <strong>Prakash*(2007)</strong>. Tin Mesoporphyrin in Conjunction with Retinoic Acid Reverses the Retinoic Acid Induced Enhancement of Phospholipase A2 Activity in vivo in Rats. Artificial Cells, Blood Substitute and Biotechnology. 35: 1&ndash;11. </p>
							</li>
							<li>
								<p class="auto-style7">AlKindi, A., Chen, G., Ge, Y., Bhathena, J., Chiu, R., <strong>Prakash*</strong>, S., Shum-Tim, D. (2007) Microencapsulated stem cell retention for localized cardiac cell delivery. Canadian Journal of Cardiology; Vol. 23:77C </p>
							</li>							
							<li>
								<p class="auto-style7">Hongmei Chen, Mitchell L Jones, Wei Ouyang, Terrence Metz, Christopher Martoni, Tasima Haque, Rebecca Cohen, Bisi Lawuyi, and Satya  <strong>Prakash*</strong> (2007). Preparation and characterization of novel polymeric microcapsules for live cell encapsulation and therapy. Cell Biochemistry and Biophysics. Vol., 47, Issue No.1, 158-162.</p>
							</li>
							<li>
								<p class="auto-style7">Afkhami F, Ouyang W, Chen H, Lawuyi B, Lim T, <strong>Prakash*</strong>*, S . (2007). Impact of orally administered microcapsules on gastrointestinal microbial flora: in-vitro investigation using computer controlled dynamic human gastrointestinal model. Artificial Cells Blood Substitute Immobilization Biotechnology. 35( 4): 359-75.</p>
							</li>
							<li>
								<p class="auto-style7">Aleksandra Malgorzata Urbanska, Wei Ouyang, Jasmine Bhathena, Christopher Martoni, and Satya <strong>Prakash*</strong> (2006).Investigation of the viability of microencapsulated live Lactobacillus acidophilus cells for their use in probiotic yogurts. International Journal of Probiotics and Prebiotics. Vol. 1, No. 2. 121-137. </p>
							</li>
							<li>
								<p class="auto-style7">Hongmei Chen, Wei Ouyang, Bisi Lawuyi, Trisna Lim, and Satya <strong>Prakash*</strong> (2006).A new method for microcapsule characterization: fluorogenic genipin can be used to characterize polymeric microcapsule membranes.Applied  Biochemistry and Biotechnology. Vol.,134, 207-231.Featured Article for the Issue.</p>
							</li>
							<li>
								<p class="auto-style7">Terrence Metz, Hongmei Chen, Devendra Amre, S.K. Das and Satya <strong>Prakash*</strong> (2006).Preparation and in-vitro analysis of microcapsule thalidomide formulation for targeted suppression of TNF-&alpha;. Drug delivery. 2006 Sep-Oct;13(5):331-337.</p>
							</li>
							<li>
								<p class="auto-style7">Hongmei Chen, Wei Ouyang, Christopher Martoni, Bisi Lawuyi, and Satya  <strong>Prakash*</strong> (2006). Genipin Cross-linked Alginate-Chitosan Microcapsules: Membrane Characterization and Optimization of Cross-linking Reaction. Biomacromolecules. Jul;7(7):2091-2098.</p>
							</li>
							<li>
								<p class="auto-style7">Satya <strong>Prakash*</strong> and Christopher John  Martoni (2006) .Towards a New Generation of Bacterial Cell Therapy:  Artificial Cells as a Vehicle for Safe and Effective Delivery of Probiotics. Applied Biochemistry and Biotechnology. 128(1):1-22. </p>
							</li>
							<li>
								<p class="auto-style7">Hongmei Chen, Wei Ouyang, Bisi Lawuyi, Christopher Martoni and Satya <strong>Prakash*</strong>(2005). Reaction of chitosan with genipin and its fluorogenic attributes for potential microcapsule membrane characterization Journal of Biomedical Materials Research Part A. 15;75(4):917-27.</p>
							</li>
							<li>
								<p class="auto-style7">Hongmei Chen, Wei Ouyang, Mitchell Jones, Tasima Haque, Bisi Lawuyi and Satya <strong>Prakash*</strong> (2005). In-vitro analysis of APA microcapsules for oral delivery of live bacterial cells. Journal of Microencapsulation 22(5):539-47.</p>
							</li>
							<li>
								<p class="auto-style7">Satya <strong>Prakash*</strong> and Jasmine Bhathena (2005). Live bacterial cells as orally delivered therapeutics. Expert Opinion on Biological Therapy. Ashley Publications Ltd. London, UK (2005) 5(10), 1281-1301.</span></p>
							</li>
							<li>
								<p class="auto-style7">Tasima Haque, Hongmei Chen, Wei Ouyang, Christopher Martoni, Bisi Lawuyi, Alexandra Urbanska, and Satya <strong>Prakash*</strong> (2005). Investigation of a new microcapsule membrane combining alginate, chitosan, polyethylene glycol and poly-l-lysine for cell transplantation applications, International Journal of Artificial Organs; 28(6):631-617.</p>
							</li>
							<li>
								<p class="auto-style7">Tasima Haque, Hongmei Chen, Wei Ouyang, Christopher Martoni, Bisi  Lawuyi, Aleksandra Malgorzata Urbanska, and Satya <strong>Prakash*</strong> (2005). Superior cell delivery features of poly-ethylene glycol incorporated alginate, chitosan and poly-l-lysine microcapsules, Molecular Pharmaceutics. Vol 2, N0.1 29-36. </p>
							</li>
							<li>
								<p class="auto-style7">Ritu Aneja, Gunjan Upadhyaya, Satya  <strong>Prakash*</strong>, Sujata K. Dass and Ramesh Chandra (2005*). Ameliorating effect of phytoestrogens on ccl4-induced oxidative stress in the livers of male wistar rats. Artificial Cells, Blood Substitute and Biotechnolog y; 33(2):201-213. </p>
							</li>
							<li>
								<p class="auto-style7">Metz, Terrence; Jones, Mitchell L.; Chen, Hongmei; Halim, Trisnawati; Mirzaei, Maryam; Haque, Tasima; Amre, Devendra; Das, Sujata K.; <strong>Prakash*</strong>Satya (2005). A New Method for Targeted Drug Delivery Using Polymeric Microcapsules: Implications for Treatment of Crohn's Disease. Cell Biochemistry and Biophysics, Volume 43, Issue 1, page 77-86.</p>
							</li>
							<li>
								<p class="auto-style7">Tasima Haque, Hongmei Chen, Wei Ouyang, Christopher Martoni, Bisi L awuyi, Aleksandra Malgorzata Urbanska, and Satya <strong>Prakash*</strong> (2005). Alginate-chitosan microcapsules: in-vitro analysis for liver cell encapsulation and therapy. Biotechnology Letters Mar; 27(5):317-322. </p>
							</li>
							<li>
								<p class="auto-style7">Ritu Jain, Manisha Tiwari, Gunjhan Upadhyaya, Satya  <strong>Prakash*</strong> and Ramesh Chandra (2005).The use of Riboflavin and Metalloporphyrins in cytochrome P-450 in Wistar Rats. Artificial Cells, Blood Substitute and Biotechnology. 2005;33(3):271-278 (listed incorrect in pubmed). </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash*</strong> S,and Jones ML (2005). Artificial Cell Therapy: New Strategies for the Therapeutic Delivery of Live Bacteria. Journal of Biomedicine Biotechnology: (1):44-56. </p>
							</li>
							<li>
								<p class="auto-style7">Mitch Lawrence Jones, Hongmei Chen, Wei Ouyang, Terrence Metz, and Satya <strong>Prakash*</strong>  (2005). Deconjugation of Bile Acids with Immobilized Genetically engineered Lactobacillus plantarum 80 (pCBH1). Applied Bionics and Biomechanics, Vol.2, No 1, 1-8. </p>
							</li>
							<li>
								<p class="auto-style7">Wei Ouyang, Hongmei Chen, Terrence Metz, Mitch Lawrence, Jones and Satya <strong>Prakash*</strong>  (2004). Artificial cell for oral delivery of live bacterial cells for therapy: preparation and in-vitro characterizations. Journal of Pharmacy and Pharmaceutical Science. 7(3)315-324. Featured   as Editorial in lead drug delivery updates and was distribute to more than 7000 drug companies and drug discovery and other researchers.</span></p>
							</li>
							<li>
								<p class="auto-style7">Terrence Metz, Devendra Amre, Mitchell L. Jones, Wei Ouyang, Hongmei Chen, Tasima Haque Christopher Martoni, and Satya <strong>Prakash*</strong> (2004). Artificial cell microcapsule containing Thalidomide as an alternative oral therapy method for Crohn&rsquo;s Disease (CD). Pediatric Gastroenterology, Hepatology and Nutrition, Page 565-571.</p>
							</li>
							<li>
								<p class="auto-style7">Satya <strong>Prakash*</strong> and Hahn Soe-Lin (2004). Strategy for cell therapy: polymers for live cell encapsulation and delivery. Trends in Biomaterials &amp; Artificial Organs, 18, 1, 24-35.</p>
							</li>
							<li>
								<p class="auto-style7">Mitch Lawrence Jones, Hongmei Chen, Wei Ouyang, Terrence Metz, and Satya <strong>Prakash*</strong> (2004). Microencapsuled Genetically Engineered Lactobacillus plantarum 80 (pCBH1) for bile acid deconjugation. Journal of Biomedicine and Biotechnology, 2004(1):61-69. </p>
							</li>
							<li>
								<p class="auto-style7">Ritu Aneja, Sujata K. Dass, Satya  <strong>Prakash*</strong> and Ramesh Chandra (2004). Effect of gossypol in association with chromium protoporphyrin on heme metabolic enzymes. Artificial Cells, Blood Substitute and 32, 1, 159-172.</p>
							</li>
							<li>
								<p class="auto-style7">Mitch Lawrence Jones, Hongmei Chen, Wei Ouyang, Terrence Metz, and Satya <strong>Prakash*</strong> (2003). Method for measuring bile acid. Journal of Medical Sciences. 23(5), 277-280. </p>
							</li>
							<li>
								<p class="auto-style7">Chow, JN, Liu ,ZC, <strong>Prakash</strong>, S and Chang*, TMS (2003). Free and Microencapsulated Lactobacillus and effects of metabolic induction on Urea Removal.Artificial Cells, Blood Substitutes and Biotechnology, Volume 31, Number 4, 425-435 . </p>
							</li>
							<li>
								<p class="auto-style7">Chang TM* and <strong>Prakash</strong> S. (2001). Procedures for microencapsulation of enzymes, cells and genetically engineered microorganisms. Molecular Biotechnology. 17(3):249-260. </p>
							</li>
							<li>
								<p class="auto-style7"><strong>Prakash</strong>, S. and Chang*, T.M.S. (2000). Artificial cells microencapsulated genetically engineered E. coli DH5 cells for the lowering of plasma creatinine in-vitro and in-vivo. Artif. Cells, Blood Substitutes &amp; Immob. Biotechnology, an International journal, Sep 28:5 397-408.</p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Chang*, T.M.S. (2000). In vitro and in vivo uric acid lowering by artificial cells containing microencapsulated genetically engineered E. coli DH5 cells. Int. J. Artif. Organs, 23:7 429-435. </span></p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Chang*, T.M.S. (1999). Growth kinetics of genetically engineered E. coli DH 5 cells in artificial cell APA membrane microcapsules: preliminary report. Artificial Cells Blood Substitute and Immob. Biotech., an International Journal (27(3), 291-301. </p>
							</li>
							<li>
								<p class="auto-style7">Chang*, T.M.S. and <strong>Prakash</strong>, S. (1999). Handbook of Cell Encapsulation: Tissue Engineering: Cell Encapsulation Technology and Therapeutics. (29) 379-391. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Chang*, T.M.S. (1999). Artificial cell microcapsules containing genetically engineered E. coli DH5 cells for in-vitro lowering of plasma potassium, phosphate, magnesium, sodium,  chloride, uric acid, cholesterol, and creatinine: a preliminary report. Artif. Cells Blood Subst. Immobil. Biotechnol. 27:5-6 475-481.</p>
							</li>
							<li>
								<p class="auto-style7">Chang*, T.M.S. and  <strong>Prakash</strong>, S. (1998). Therapeutic  uses of microencapsulated genetically engineered cells. Molecular Medicine Today (221-227). Features the cover page of the issue. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Chang*, T.M.S. (1998). Growth and  survival of renal failure rats that received oral microencapsulated  genetically engineered E. coli DH5 cells for urea removal. Artificial Cells Blood Substitute and Immob. Biotech., an International Journal,26(1)   35-51.</p>
							</li>
							<li>
								<p class="auto-style7">Chang*, T.M.S. and <strong>Prakash</strong>, S.(1997). Artificial cells for bioencapsulation of cells and genetically engineered E. coli for cell therapy, gene therapy, and removal of urea and ammonia. Methods in Molecular Biology, 63, 343-348. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Chang*, T.M.S. (1996). Microencapsulated  genetically engineered E. coli DH5 cells for plasma urea and ammonia  removal based on: 1. Column bioreactor and 2. Oral administration in  uremic rats. Artificial Cells Blood Substitute and Immobilization Biotechnology, an International Journal,24(3) 201-218. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Chang*, T.M.S. (1996). Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats. Nature Medicine,2(8) 893-887. (Impact Factor (IF) for Nature Medicine was 27.12 compared to IF for Nature =28, and IF for Science 28.65 in year 1998 by science citation index).</p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Chang*, T.M.S. (1995). IEEE Transaction in Biomedical Engineering, 7,111-112.</p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Chang*, T.M.S. (1995). Preparation and in-vitro analysis of Engineered E. coli DH5 cells, microencapsulated in artificial cells for urea and ammonia removal. Biotechnology and Bioengineering, 46, 687-697.</p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Chang*, T.M.S. (1993). Genetically engineered E. coli cells containing K. aerogenes gene, microencapsulated in artificial cells for urea and ammonia removal. Biomaterials Artificial Cells and Immobilization Biotechnology, 21 (5), 629-636.</p>
							</li>

						</ol> 
		    	</div>
		    	<div class="tab-pane fade" id="pill-books" role="tabpanel" aria-labelledby="pill-books-tab">
		    		<h1 class="mt-2 mb-2">Books</h1>
		    		<hr>	
						<ol>
							<li  >
								<p class="auto-style7">Satya <strong>Prakash*</strong> (Editor), Dominique Shum Tim (Editor)  (2008). Stem Cell Bioengineering and Tissue Microenvironment, World Scientific Publishing Co. Inc . Hong Kong . (in press).</p>
							</li>
							<li>
								<p class="auto-style7">Satya <strong>Prakash*</strong> (Editor) (2007). Artificial Cell, Cell Engineering and Therapy, Wood-Head Publishing Limited, Cambridge, CB1 6AH, U.K.. 
									<a href="http://www.woodheadpublishing.com/en/book.aspx?bookID=907"><span class="auto-style7">http://www.woodheadpublishing.com/en/book.aspx?bookID=907</span></a>
								</p>
							</li>
						</ol>
				</div>

		    	<div class="tab-pane fade" id="pill-revBooks" role="tabpanel" aria-labelledby="pill-revBooks-tab">
		    		<h1 class="mt-2 mb-2">Reviewed Book Chapters</h1>
		    		<hr>
						<ol>
							<li>
								<p class="auto-style7">Paul, A., Bhathena, J. Satya <strong>Prakash*</strong>. (2011). Stem cell bioengineering and microencapsulation: current perspective and future potentials. Stem Cell Bioengineering and Tissue Engineering Microenvironments. World Scientific Publishing Co. Inc., US. (in press)</p>
							</li>
							<li>
								<p class="auto-style7">Barbara Ann Jardin, Cynthia B. Elias, and Satya <strong>Prakash*</strong> (2010). Expression of a secreated protein in mammalian cells using baculovirus particles. Methods in Molecular Biology entitled &quot;Protein Expression in Mammalian Cells (Ed. James L. Hartley) (in press). </p>
							</li>
							<li>
								<p class="auto-style7">Satya <strong>Prakash*</strong> (2010). Introduction to Probiotics and Human Health. Probiotics and human health: Technological Advancements and Clinical Updates (World Scientific Publishing Co. Inc., USA. (in press).</p>
							</li>
							<li>
								<p class="auto-style7">Satya <strong>Prakash*</strong> (2010). Probiotics clinical updates. World Scientific Publishing Co. Inc., USA. (in press).</p>
							</li>
							<li>
								<p class="auto-style7">Satya <strong>Prakash*</strong> (2010). Introduction to stem cell bioengineering. Stem cell bioengineering and tissue microenvironments. World Scientific Publishing Co. Inc., USA. (in press).</p>
							</li>
							<li>
								<p class="auto-style7">Satya  <strong>Prakash</strong>, Meenakshi Malhotra, Venkatesh Rengaswamy (2010) Non-viral siRNA delivery and gene silencing for neurodegenerative diseases; RNA interference from laboratory to clinical application. Methods in Molecular Biology Vol. 623, 211-229. (book chapter)</p>
							</li>
							<li>
								<p class="auto-style7">Satya <strong>Prakash*</strong>(2008). Introduction to Probiotics and Human Health. Probiotics and human health: Technological Advancements and Clinical Updates. World Scientific Publishing Co. Inc ., USA . (in press). </span></p>
							</li>
							<li>
								<p class="auto-style7">Satya <strong>Prakash*</strong> (2008). Probiotics clinical updates. World Scientific Publishing Co. Inc., USA . (in press). </p>
							</li>
							<li>
								<p class="auto-style7">Satya <strong>Prakash*</strong> (2008). Microencapsulation to Improve Cell Delivery in Myocardial Cell Therapy. Stem cell Bioengineering and Tissue microenvironments. World Scientific Publishing Co. Inc., USA . (in press). </p>
							</li>
							<li>
								<p class="auto-style7">Satya <strong>Prakash*</strong>, Arghya Paul and Jasmine Bhathena (2008). Stem cell bioengineering and microencapsulation: potential and limitation of artificial cells. Stem cell Bioengineering and Tissue microenvironments. World Scientific Publishing Co. Inc ., USA . (in press). </p>
							</li>
							<li>
								<p class="auto-style7">Satya <strong>Prakash*</strong>(2007). The artificial cell design evolution and application. Artificial Cell, Cell Engineering and Therapy, Woodhead Publishing Limited, Abington Hall, Abington, Cambridge, CB1 6AH, England.</p>
							</li>
							<li>
								<p class="auto-style7">Satya <strong>Prakash*</strong>, Jasmine Bhathena and Hongmei Chen (2007). Introduction to artificial cell: concept, history, design, current status and future prospective, Pages 3-30, Artificial Cell, Cell Engineering and Therapy. Woodhead Publishing Limited, Abington Hall, Abington, Cambridge, CB1 6AH, England.</p>
							</li>
							<li>
								<p class="auto-style7">Satya  <strong>Prakash*</strong> and T. Halim and W.P. Ouyang (2007). Artificial cells for the treatment of kidney failure. Pages 366-381 Artificial Cell, Cell Engineering and Therapy, Woodhead Publishing Limited, Abington Hall, Abington, Cambridge, CB1 6AH, England.</p>
							</li>
							<li>
								<p class="auto-style7">Satya <strong>Prakash*</strong> J. Bhathena and A. Urbanska (2007). Oral delivery of live bacterial cell for therapy. Pages 189-209. Artificial Cell, Cell Engineering and Therapy, Woodhead Publishing Limited, Abington Hall, Abington, Cambridge, CB1 6AH, England.</p>
							</li>
							<li>
								<p class="auto-style7">D. Amre, R. D. Amre and S. <strong>Prakash*</strong> (2007). Inflammatory Bowel Diseases: current treatment strategies and potentials of artificial cells microcapsules. Pages 454-465. Artificial Cell, Cell Engineering and Therapy, Woodhead Publishing Limited, Abington Hall, Abington, Cambridge, CB1 6AH, England.</p>
							</li>
							<li>
								<p class="auto-style7">Satya <strong>Prakash*</strong> and Jasmine Bhathena (2006). Microencapsulation. Encyclopedia of Biomedical Engineering, (edited by Prof. Metin Akay). John Wiley &amp; Sons, Inc., USA.</p>
							</li>
							<li>
								<p class="auto-style7">Chang* TM.S. and <strong>Prakash</strong>, S. (2001). Removal of urea in uremia and ammonia with emphasis on the use of artificial cells for encapsulation of genetically engineered cells. World Encyclopedia of Cell Therapy (Ed. R. Langer and Kunkler). </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Chang*, T.M.S. (2000). Artificial cells containing genetically engineered E. coli DH5 cells for the removal of unwanted waste metabolites and electrolytes. Biotechnology Annual Review, Vol.7.</p>
							</li>
							<li>
								<p class="auto-style7">Chang* T.M.S. and <strong>Prakash</strong>, S. (2000). Artificial Cells for Urea and Ammonia Removals. Molecular Biotechnology. 17(3):249-260.</p>
							</li>
							<li>
								<p class="auto-style7">Chang*, T.M.S. and <strong>Prakash</strong>, S. (1999). &quot;Removal of urea in uremia and ammonia in liver failure with emphasis on the use of artificial cells containing genetically engineered cells&quot;, for the book, Handbook of Cell Encapsulation. Handbook of Cell Encapsulation. (Editors: W.M. Kuhtreiber &amp; R.P. Lanza, Birkhauser &amp; Springer-Verlag) ISBN 0-8176-4010-X,</p>
							</li>
						</ol>
		    	</div>

		    	<div class="tab-pane fade" id="pill-patents" role="tabpanel" aria-labelledby="pill-patents-tab">
		    		<h1 class="mt-2 mb-2"> Patents</h1>
		    		<hr>
						<ol>
							<li>
								<p class="auto-style7"> Jones  M and <strong>Prakash*</strong> S (2012). Ingestible  medical device. US 61/600,029. Filed 17 Feb, 2012.</p>
							</li>
							<li>
								<p class="auto-style7">Jones  Mitchell, Christopher Martoni and <strong>Prakash</strong>, S. (2012). Bacterial composition for prophylaxis  and treatment of degenerative diseases. European Patent # 10-2011-7028620. Filed January, 16 2012.</p>
							</li>
							<li>
								<p class="auto-style7"> Jones  Mitchell, Christopher Martoni and <strong>Prakash</strong>, S. (2012). Bacterial composition for prophylaxis  and treatment of degenerative diseases. Russian Patent # 2011148944. Filled  January, 21, 2012. </p>
							</li>
							<li>
								<p class="auto-style7">Satya <strong>Prakash</strong>, Afshan Afsar Khan, Arghya  Paul, Dominique Shum-Tim (2012). Novel method of using polymeric  micro/nano-particles for stem cell derived growth factor cocktail delivery in  wound healing and tissue regeneration applications. ROI-12033. Filed May1, 2012. </p>
							</li>
							<li>
								<p class="auto-style7">Satya <strong>Prakash</strong> and Meenakshi Malhotra (2012) Non-viral nanaoparticle based delivery system US 61/660,139, Filed June 15, 2012 </p>
							</li>
							<li>
								<p class="auto-style7">Jones Mitchell, Christopher Martoni and <strong>Prakash</strong>, S. (2011). Bacterial composition for prophylaxis and treatment of degenerative diseases. Korean National Phase Patent # 2011148944. Filled Dec 12, 2011. </p>
							</li>
							<li>
								<p class="auto-style7">Jones  M. L. and <strong>Prakash</strong>, S. (2011). Epsilon poly-l-lysine capsules. European Patent. EP10838481.9, 11/12/2011. </p>
							</li>
							<li>
								<p class="auto-style7">Jones  Mitchell, and <strong>Prakash</strong>,  S. (2011). Nitric oxide device and method for wound healing, treatment of  dermatological disorders and microbial infections. Japanese Patent # 2011-515032 Filled May 11, 2011. </p>
							</li>
							<li>
								<p class="auto-style7">Jones  Mitchell, Christopher Martoni and <strong>Prakash</strong>, S. (2011). Bacterial composition for prophylaxis  and treatment of degenerative diseases. Japanese Patent # F3640A1 Filled Dec 20, 2011. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Malhotra, M. (2011). Non-viral  nanaoparticle based delivery system. U.S. Provisional Patent.US 61/497,088  Filed on June 15, 2011.</p>
							</li>

							<li>
								<p class="auto-style7">Jones  Mitchell, Christopher Martoni and <strong>Prakash</strong>, S. (2011). Bacterial composition for prophylaxis  and treatment of degenerative diseases. Chinese Patent # 044218-8001CN01 Filled  Dec 18, 2011. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Jonathan Kanevsky and  Mireco Gerodino (2010). Device and method for reducing scar formation. US  Provisional Patent (2010). Filed in 8, Oct 2010. Commercialized. </p>
							</li>							
							<li>
								<p class="auto-style7">Jones Mitchell and Satya <strong>Prakash</strong> (2010). Bacterial  composition for prophylaxis and treatment of degenerative diseases. Australian  Capital Territory Patent # 2010242498 Filed April 30, 2010.</p>
							</li>
							<li>
								<p class="auto-style7">Jones Mitchell and Satya <strong>Prakash</strong> (2010). Bacterial  composition for prophylaxis and treatment of degenerative diseases. Tokyo. Japanese Patent 2012-5075533. Filed April 30, 2010.</p>
							</li>
							<li>
								<p class="auto-style7">Jones Mitchell and Satya <strong>Prakash</strong> (2010). Bacterial  composition for prophylaxis and treatment of degenerative diseases. Shanghai.  Chinese Patent: CN201080029643.9 Filed April 30, 2010. </p>
							</li>
							<li>
								<p class="auto-style7">Jones Mitchell, Christopher Martoni and <strong>Prakash</strong>, S. (2010). Bacterial composition for prophylaxis  and treatment of degenerative diseases. International PCT WO/2010/124387. Filed  30 April 2010. </p>
							</li>
							<li>
								<p class="auto-style7">Jones Mitchell, Bhathena, J and <strong>Prakash</strong>,  S. (2010). Prevention and therapy of metabolic syndrome using probiotics. U.S.  61/349,270. Filed May 28, 2010. Commercialized. </p>
							</li>
							<li>
								<p class="auto-style7">Jones M.  L. and  <strong>Prakash</strong>, S. (2010).  Epsilon poly-l-lysine capsules. International Patent.  PCT/CA2010/002057, 22/12/2010. </p>
							</li>
							<li>
								<p class="auto-style7">Jones Mitchell and <strong>Prakash</strong>, S. (2010). Bacterial composition for prophylaxis and treatment of degenerative diseases. Canadian Patent # 13935-38. </p>
							</li>
							<li>
								<p class="auto-style7">Jones Mitchell and Satya <strong>Prakash</strong> (2009). Nitric  oxide compositions and devices and methods for cosmesis. Washington Patent US  61/153,696 Filed on Feb 19, 2009 (Withdrawn) </p>
							</li>
							<li>
								<p class="auto-style7">Jones Mitchell and Satya <strong>Prakash</strong> (2009). Nitric  oxide compositions and devices and methods for cosmesis. WO/2009155690. Filed  June 23, 2009. (Withdrawn) </p>
							</li>
							<li>
								<p class="auto-style7">Jones Mitchell, Christopher Martoni and <strong>Prakash</strong>, S. (2009). Bacterial composition for prophylaxis and  treatment of degenerative diseases. US Provisional Patent 61/174,740. Filed May  1, 2009.</p>
							</li>
							<li>
								<p class="auto-style7">Jones  M.L. and <strong>Prakash</strong>,S.  (2009). Nitric oxide device and method for wound healing, treatment of  dermatological disorders and microbial infections. International Patent  WO/2009/ 155689. </p>
							</li>
							<li>
								<p class="auto-style7">M.L.  Jones and <strong>Prakash</strong>, S. (2009). Nitric oxide device and method for wound healing, treatment of dermatological  disorders and microbial infections. US provisional. U.S. 61/075,040 filed June  24, 2008 and U.S. 61/097,978 filed September 18, 2008, and U.S. 61/166,430,  April, 3, 2009. Note: two improvement US provisional patents. </p>
							</li>
							<li>
								<p class="auto-style7">Jones  M.L. and <strong>Prakash</strong>, S.  (2009). Nitric oxide compositions and devices and methods for cosmesis. International Patent. WO/2009/155689. </p>
							</li>
							<li>
								<p class="auto-style7">Jones  M.L. and <strong>Prakash</strong>,S. (2009).  Nitric oxide compositions and devices and methods for cosmesis. U.S. Provisional Patent. Application # U.S. 61/075,040. Filed 19 Feb, 2009. </p>
							</li>
							<li>
								<p class="auto-style7">Jones M.L, Christopher Martoni and <strong>Prakash</strong>, S. (2009). Epsilon  poly-l-lysine capsules. U.S. Provisional Patent 61/289727. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash*</strong>, S. and M.L. Jones (2009) Cell and Enzyme composition for modulating bile  acids, cholesterol and triglycerides. US Continuation Patent #12/492,629.  Filed, June 26, 2009.</p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and M.L. Jones (2008). Nitric oxide  device and methods for wound healing. U.S. Provisional Patent. # 61/097978. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Saffa, S.  (2008). A novel, natural, non-toxic, fluorescent emitting  nanoparticle therapeutic molecule delivery system. US Provisional Patent </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Jones, M.L. (2008). Novel wound healing formulation. U.S. Provision Patent.  Application No. 61/097978.</p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Bhathena, J.  (2008). Novel method to produce enzyme feruloyl esterase and ferulic  acid and their application thereof. International  PCT patent for U.S., UK, EU, India, Canada and Japan. PCT/CAA-2008/000585. 8/2008. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Bhathena, J. (2007).  Microcapsule formulation and their use in liver failure therapy. International PCT. Filed on 13 Sept 2007).</p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>,S. and. Urbanska A.  M. (2007). Microcapsule yoghurt formulation and their use in probiotic delivery. International PCT application (filed).</p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and J. Bhathena  (2007). Novel method to produce enzyme feruloyl esterase and ferulic acid and their application thereof US  Provisional Patent. # 1464767. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and J. Bhathena  (2006). Microcapsule formulation and their use in liver failure therapy  delivery. US Provisional Patent. # 60/824/793.</p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash*</strong>, S. and Jones, M.L. (2006). Cells enzyme and its  compositions for modulating bile acids, cholesterol and tri-glycerides. Hong  Kong Patent HK# 06110718.4. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash*</strong>, S., Chen H, Nalamasu, O, Raja P and Ajayan P.M. (2006). Microcapsule carbon nanotube device. International Patent  PCT Application No.: PCT/US2006/045412. docket No. 3965.1000002, Filed on Nov  21, 2006.</p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Aleksandra  Malgorzata Urbanska (2006). Microcapsule yoghurt formulation and their use in  probiotic delivery. US Provisional Patent. 14647-59. 7/2006 </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash*</strong>, S., Chen H, Nalamasu, O, Raja P and Ajayan P.M. (2005). Microcapsule carbon nanotube device. U.S. Provisional Application No. 60/739,593. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash*</strong>, S. and M.L. Jones (2004). Bacterial cells for bile acid  intake and/or lowering cholesterol: immobilized, microencapsulated. European  Patent # 04715862. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash*</strong>, S. and M.L. Jones. (2004). Bacterial cells for bile acid  intake and/or lowering cholesterol: immobilized, Microencapsulated. US Patent #  7,939,061.</p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash*</strong>, S. and M.L. Jones (2004). Cell and enzyme compositions for  modulating bile acids, cholesterol and triglycerides. Canada Patent #2,517,245. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash*</strong>, S. and M.L. Jones (2004) Cell  and Enzyme Compositions for Modulating Bile Acids, Cholesterol and Triglycerides. International PCT WO/2004/076657. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash*</strong>, S.and M.L. Jones (2003). Microencapsulated and/or  Immobilized Enzyme and/or Bacteria for Lowering Bile Acid and/or Cholesterol. US  Provisional Patent (US 60/450,334). Filed Feb 28, 2003.</p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Chang, T.M.S. (2002). Microencapsulated genetically  engineered microorganisms for clinical application. European  Union (EU) Patent. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Chang, T.M.S.  (2002). Micro-organismes  microencapsules issus du genie genetique pour applications cliniques. CA Patent # 2243352.</p>
							</li>
							<li>
								<p class="auto-style7">Chang,  T.M.S. and <strong>Prakash</strong>, S. (2001).  Microencapsulated genetically engineered microorganisms for clinical  application. U.S. Patent: No.621785.</p>
							</li>
							<li>
								<p class="auto-style7">Chang,  T.M.S. and <strong>Prakash</strong>, S. (2001).  Artificial cell containing genetically engineered microorganisms for clinical  application JAPANIES PATENT control Number 9526371, 1770-138JP.</p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Chang, T.M.S. (2001). Artificial cells  containing genetically engineered E. coli DH5 cells for  lowering of plasma electrolyte. International PATENT (PTC) for EU, UK, USA,  Canada, Japan, India, &amp; China :S. No. 9899073.</p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Chang, T.M.S. (1999). Artificial  Cells containing genetically engineered E. coli DH5 cells for in-vitro lowering  of plasma K, Na, Mg, Cl, Creatinine, Cholesterol, Bilirubin, &amp; Uric Acid  for various clinical applications. U.S. Priority Patent S.No.60/ 131,46816. </p>
							</li>
							<li>
								<p class="auto-style7">Chang, T.M.S. and <strong>Prakash</strong>, S. (1997). Microencapsulated genetically engineered microorganisms for lowering plasma  urea and ammonia for clinical applications. International PATENT (PTC) for EU,  UK, USA, Canada, and Japan (PCT/CA97/00040): </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Chang, T.M.S (1996). Microencapsulated genetically engineered E. coli DH5  cells for clinical applications. British Priority Patent No.960133-9.</p>
							</li>
						</ol>
		    	</div>

		    	<div class="tab-pane fade" id="pill-abstract" role="tabpanel" aria-labelledby="pill-abstract-tab">
					<h1 class="mt-2 mb-2">Abstracts</h1>
					<hr>
						<ol>
							<li>
								<p class="auto-style7">Paul A, Shum-Tim D, <strong>Prakash</strong> S (2012). Microencapsulation Technology and Nanomedicine for Myocardial Therapy. 12th McGill Biomedical Graduate Conference, Montreal. Won Best Graduate Research Poster Award.</p>
							</li>
							<li>
								<p class="auto-style7">Saha S, Tomaro-Duchesneau C, Malhotra M, Al-Salami H, Kahouli I, <strong>Prakash</strong> S. (2011) Development of an in vitro oral ecosystem model to investigate probiotics as a therapeutic for maintaining oral health. Canadian Society for Pharmaceutical Sciences, Canadian Society of Pharmacology and Therapeutics, Controlled Release Society and the Natural Health Products Research  Society of Canada&#8211;Multidisciplinary Approaches to Modern Therapeutics:  Joining Forces for a Healthier Tomorrow. Montreal, QC. </p>
							</li>
							<li>
								<p class="auto-style7">Saha S, Tomaro-Duchesneau C, Malhotra M, Tabrizian M, <strong>Prakash</strong> S. (2011) Role of Probiotics in Dental Caries Causing Organism Streptococcus mutans and Other Bacterial Systems: In-Vitro Analysis. McGill University - Faculty of Dentistry &#8211; 6th Annual Research Day, Montreal, QC.</span></p>
							</li>
							<li>
								<p class="auto-style7">Tomaro-Duchesneau C, Saha S, Malhotra M, Al-Salami H, Kahouli I, <strong>Prakash</strong> S. (2011) Artificial cell APA microcapsules for the delivery of a Lactobacillus  fermentum based therapeutic. Canadian Society for Pharmaceutical Sciences, Canadian Society of Pharmacology and Therapeutics, Controlled Release  Society and the Natural Health Products Research Society of Canada&#8211;Multidisciplinary Approaches to Modern Therapeutics: Joining Forces for a Healthier Tomorrow. </p>
							</li>
							<li>
								<p class="auto-style76">Tomaro-Duchesneau C, Saha S, Malhotra M, Al-Salami H, Coussa-Charley  <strong>Prakash</strong> S. (2011) Selection and characterization of FAE active probiotic bacteria for the development of therapeutics. International Scientific Conference on Probiotics and Prebiotics. Kosice, Slovakia.</p>
							</li>
							<li>
								<p class="auto-style7">Malhotra M, Tomaro-Duchesneau C, Saha S, Chemali R, Kahouli I and <strong>Prakash</strong> S. (2011) Importance of cell targeting peptides for targeted delivery of nanoparticles in vitro and in vivo studies - A Review. Canadian Society for Pharmaceutical Sciences, Canadian Society   of Pharmacology and Therapeutics, Controlled Release Society and the Natural Health Products Research Society of Canada&#8211;Multidisciplinary  Approaches to Modern Therapeutics: Joining Forces for a Healthier Tomorrow. </p>
							</li>
							<li>
								<p class="auto-style7">Kahouli I, Tomaro-Duchesneau C, Malhotra M, Al-Salami H, Saha S, <strong>Prakash</strong> S. (2011) Effect of Lactobacillus acidophilus supernatant on colon cancer cell proliferation and polyamine synthesis. Canadian Society for Pharmaceutical Sciences, Canadian Society of Pharmacology and Therapeutics, Controlled Release Society and the Natural Health Products Research Society of Canada&#8211;Multidisciplinary Approaches to Modern Therapeutics: Joining Forces for a Healthier Tomorrow </p>
							</li>
							<li>
								<p class="auto-style7">Rodes L, Coussa-Charley M, Kahouli I, Al-Salami H,<strong>Prakash</strong> S. (2011) In vitro investigation of the human gut microbiota using a computer-controlled dynamic human gastrointestinal model Microbial Communities as Drivers of Ecosystem Complexity, Colorado, USA</span></p>
							</li>
							<li>
								<p class="auto-style7">Al-Salami H, Tomaro-Duchesneau C, Rodes L, Kahouli I, Saha S, Coussa-Charley M, <strong>Prakash</strong> S. (2010) In vitro gastrointestinal model for probiotic research: potentials and limitations.6th International Symposium ''Probiotics and Health : Key Findings. New Directions. Montreal, QC</p>
							</li>
							<li>
								<p class="auto-style7">Malhotra M and <strong>Prakash</strong> S. (2010) Surface functionalized chitosan nanoparticles for gene delivery. Particles 2010. May 22-25, 2010. Lake Buena Vista, Florida, USA. </p>
							</li>
							<li>
								<p class="auto-style7">Malhotra M, Paul A and <strong>Prakash</strong> S (2010). Peptide tagged, non-toxic chitosan nanoparticles for enhanced siRNA delivery. RNAi and miRNA world congress. May 5-7, 2010. Boston, MA, USA.</p>
							</li>
							<li>
								<p class="auto-style7">A Paul, Dominique Shum-Tim, Satya <strong>Prakash</strong> (2010). BacMam virus mediated gene transfer to cardiomyocytes and marrow stromal cells: Implications in myocardial therapy. 62nd Indian Pharmaceutical Congress, IPC (2010), Manipal University. </p>
							</li>
							<li>
								<p class="auto-style7">A Paul, Afshan A. Khan, Dominique Shum-Tim, Satya <strong>Prakash</strong>(2010). Microencapsulated genetically modified  stem cells for heart tissue regeneration. Second World Congress   of International Academy of NanoMedicine (IANM), (2010), Antalya, Turkey.</p>
							</li>
							<li>
								<p class="auto-style7">A Paul, Hani Al-Salami, Dominique Shum-Tim, Cynthia B. Elias, Satya <strong>Prakash</strong>< (2010). Insect cells for cytokine production and stem cell mediated gene therapy applications. 7th Annual PEGS&ndash;the essential protein engineering summit, (2010), Boston, US. </p>
							</li>
							<li>
								<p class="auto-style7">Sinno H, Lutfy J, Jardin B, Brimo, F, Malhotra M, Beckman L, Winocour S, Williams B, <strong>Prakash*</strong> S (2010). Topical Complement C3 in Collagen Formulation Accelerates Wound Healing. 89th annual meeting for the American Association of Plastic Surgeons (oral presentation) Plastic &amp; Reconstructive Surgery Journal Monday, March 22, 2010. Abstract No. 1, Page 113. Best Prize for Poster presentation (2nd Place).</p>
							</li>
							<li>
								<p class="auto-style7">Paul A, Cantor A, Abbasi S, Khan A, Shum-Tim D, <strong>Prakash</strong> S (2010). Biocompatible Polymeric Microcapsules: A Novel Delivery System for Efficient Myocardial Delivery of Human Mesenchymal Stem-cells. Canadian Cardiovascular Congress 2010, Montreal. Canada. </p>
							</li>
							<li>
								<p class="auto-style7">Abbasi S, Sebak S, Malhotra M, <strong>Prakash</strong> >S (2010).  Noscapine-loaded Nanoparticles Designed to Specifically Target Breast Cancer, Invited Plenary speakers Nanotech Conference 4th MPA, Portugal.  (April 2010).</p>
							</li>
							<li>
								<p class="auto-style7">Malhotra M, Kulamarva A, Paul A and S <strong>Prakash*</strong> (2009). Surface functionalized chitosan nanoparticles for targeted gene delivery  in-vitro. Nanotoday 2009, August 2-5, Singapore.</p>
							</li>
							<li>
								<p class="auto-style7">Malhotra M, Paul A, Kulamarva A and <strong>Prakash*</strong>S (2009). Improved tranfection of chitosan nanoparticles, surface coated with cell penetrating peptides. 6th Interdisciplinary Graduate Student Research Symposium (IGSRS), March 26-27, McGill University, Montreal, Canada. </p>
							</li>
							<li>
								<p class="auto-style7">Fatemeh Afkhami, Satya <strong>Prakash</strong>, Yves Durocher* (2009). Impact of VEGF165b sialylation level and IFNa2b O-glycosylation on their pharmacokinetic behaviors in rats. Canadian Society for Pharmaceutical Sciences (CSPS). 12th Annual Meeting &amp; Symposium June 3-6, oronto, Ontario, Canada.</p>
							</li>
							<li>
								<p class="auto-style7">Fatemeh Afkhami, Satya <strong>Prakash</strong>, Yves Durocher* (2009). Local delivery of VEGF165b and IFNa by microencapsulated cells as potential antiangiogenic therapy. 35 th Northeast Bioengineering Conference(April), Boston, USA. Won 3rd best research abstract award&rdquo;.</p>
							</li>
							<li>
								<p class="auto-style7">Malhotra M, Kulamarva A, Paul A and <strong>Prakash*</strong>, S. (2009). Characterizing PEGylated chitosan nanoparticles in terms of size and zeta potential for gene delivery applications. NSTI Nanotech 2009, May 3-7, Houston, Texas, USA.</p>
							</li>
							<li>
								<p class="auto-style7">A Paul, M Malhotra, C Elias, D Shum-Tim, S  <strong>Prakash</strong> (2009)Viral vector based gene therapy for angiogenesis of damaged cardiac tissues: a novel approach.  McGill University Biomedical Engineering Student Research Day. Best Presentation (Bioengineering, Biomaterials and Cell Therapy Category), Montreal, Quebec, Canada.</p>
							</li>
							<li>
								<p class="auto-style7">A Paul, M Malhotra, A Kulamarva, Satya <strong>Prakash</strong> (2009). Application of recombinant insect cell viruses for gene therapy of cardiovascular diseases. The Sixth World Congress on Industrial Biotechnology &amp; Bioprocessing, July 19-22, Montreal, Canada.</p>
							</li>
							<li>
								<p class="auto-style7">Arghya Paul and Satya <strong>Prakash*</strong> (2009). Efficient Gene Delivery to Mouse Brain Neuroblast Cells using Recombinant Viral Particles. 3rd International Congress of Nanobiotechnology and Nanomedicine 2009. June 22-24, San Francisco, USA.</p>
							</li>
							<li>
								<p class="auto-style7">Kulamarva A., Malhotra M., Paul A. and <strong>Prakash*</strong> S.(2009). Polymeric membrane carbon nanotube devices for targeted drug delivery. NSTI Nanotechnology Conference and Trade Show, May 3-7, Houston, Texas, USA.</p>
							</li>
							<li>
								<p class="auto-style7">Kumarva, A., Bhathena, J., Paul A, Sinno H., Malhotra M, and S. <strong>Prakash*</strong> (2009). Polymeric membrane microcapsule carbon nanotube devices for targeted delivery. Nanobiophysics, Nanochemistry, Nanomedicine &amp; Nanotoxicology Conference 2009, Antigua and Barbuda, January 21-25.</p>
							</li>
							<li>
								<p class="auto-style7">Sinno H, Lutfy J, Jardin B, Brimo, F, Malhotra M, Beckman L, Winocour S, Williams B,<strong>Prakash*</strong> S (2009). Early Increased Wound Healing Strength with Topical Complement C3 63rd annual meeting for the Canadian Society of Plastic Surgeons (oral presentation). Canadian Journal of Plastic Surgery. 2009 Vol 17 (2) pg 50 Abstract No.42.</p>
							</li>
							<li>
								<p class="auto-style7">Sinno H, Lutfy J, Jardin B, Brimo, F, Malhotra M, Beckman L, Winocour S, Williams B, <strong>Prakash*</strong> S 2009) Complement C3 Increases Wound Strength in Rats. Association for Specialists in Plastic and Esthetic Surgery of Quebec, ASCPEQ, March, Abstract # 23,pg 27.</p>
							</li>
							<li>
								<p class="auto-style7">Paul, M. Malhotra, B. A. Jardin, C. B. Elias, S. <strong>Prakash*</strong>(2009). Baculovirus mediated gene delivery for rapid expression of transporter  gene in mouse neuroblastoma cells: In vitro analysis. Dendritic Cells   Conference, Banff, Canada.></p>
							</li>
							<li>
								<p class="auto-style7">Arghya Paul, Barbara Jardin, Dominique Shum-Tim, Cynthia Elias, Satya  <strong>Prakash*</strong> (2009). Gene therapy of injured vascular tissues using nuclear polyhedrosis virus. Canadian Medical and Biological Engineering Society Conference, Calgary, Canada.</p>
							</li>
							<li>
								<p class="auto-style7">Malhotra M, Kulamarva A, Paul A and <strong>Prakash*</strong> S, (2009). Surface functionalized chitosan nanoparticles for gene delivery. 32nd Canadian Medical and Biological Engineering Conference CMBEC32, May 20-22, Calgary, Alberta.</p>
							</li>
							<li>
								<p class="auto-style7">Cynthia Elias, A Paul, Barbara Jardin, S. <strong>Prakash</strong> and Dominique Shum-Tim. (2009) Baculoviruses: Practical aspects of their use as Gene therapy vectors. 12th International Meeting on Baculovirus and Insect Cell Culture, TX, USA.</p>
							</li>
							<li>
								<p class="auto-style7">A. Paul, B.A. Jardin, D. Shum-Tim, C.B. Elias, S. <strong>Prakash*</strong> (2009). Nuclear polyhedrosis virus mediated gene delivery for rapid angiogenesis of damaged vascular tissues. 12th International Meeting on Baculovirus and Insect Cell Culture February 2-4, 2009, TX, USA.</p>
							</li>
							<li>
								<p class="auto-style7">A. Paul, M Hamoudeh, M Malhotra, C Elias, D Shum-Tim, S  <strong>Prakash</strong> (2009). Viral vector based gene therapy for angiogenesis of damaged cardiac tissues: a novel approach. Canadian Cardiovascular Conference, 2008, Toronto, Canada.</p>
							</li>
							<li>
								<p class="auto-style7">Arun Kulamarva, Bhathena, J., Malhotra M, Paul A and <strong>Prakash*</strong> S. (2008). Targeted carbon nanotube delivery for biomedical applications:  preparation and in-vitro analysis. Nanomaterials Conference 2008, Playa del Carmen, Mexico. December 7- 10.</p>
							</li>
							<li>
								<p class="auto-style7">Urbanska AM , Bhathena J, Martoni C, and <strong>Prakash</strong>S. (2008). Lactobacillus acidophilus live bacterial cells lowers intestinal inflammation in Apc(Min/+) mice, (Oct 15-17), Korsakov, Poland. </p>
							</li>
							<li>
								<p class="auto-style7">Bhathena J., Martoni C., Kulamarva A ., Urbanska A.M, Malhotra, M. and <strong>Prakash</strong> S. (2008) In-vitro analysis of microencapsulated bacterial cells for augmentation of ferulic acid in the gastrointestinal tract. Ferulate '08: An International Conference on Hydroxycinnamates and Related Plant Phenolics, Minneapolis/St. Paul, USA. </p>
							</li>
							<li>
								<p class="auto-style7">Urbanska AM , Bhathena J, Martoni C, and <strong>Prakash</strong> S. (2008). Oral delivery of microencapsulated Lactobacillus acidophilus live bacterial cells lowers intestinal inflammation in Apc(Min/+) mice,  (June 4-7). Poprad, Slovakia.</p>
							</li>
							<li>
								<p class="auto-style7">Arun Kulamarva, Jasmine Bhathena, Meenakshi Malhotra, Safaa Sebak and Satya <strong>Prakash</strong>(2008). In-vitro cytotoxicity of carbon nanotubes for targeted delivery applications. 11th Canadian Society for Pharmaceutical Sciences (CSPS) Annual Meeting, (May 22-25) . Banff, Alberta, Canada. Cedarlane Award of Excellence- Best Poster Presentation by a Trainee</p>
							</li>
							<li>
								<p class="auto-style7">Bhathena J ., Kulamarva A, Urbanska A.M, Martoni C and <strong>Prakash</strong> S. (2008) Live microencapsulated Lactobacillus fermentum 11976 can be  used to augment ferulic acid in the gastrointestinal tract: Preparation  and in-vitro analysis. 11th Canadian Society for Pharmaceutical Sciences (CSPS) Annual Meeting. Banff, Alberta, Canada.</p>
							</li>
							<li>
								<p class="auto-style7">Malhotra M, Kulamarva A, Sebak S, Bhathena J, <strong>Prakash*</strong>, S. (2008). Characterization of low molecular weight chitosan nanoparticles as a delivery carrier for therapeutic molecules 8 th Annual McGill Biomedical  Graduate Conference February 26, Montreal, Canada.</p>
							</li>
							<li>
								<p class="auto-style7">Malhotra Meenakshi, Kulamarva, Arghya Paul, Misara Hamoudeh, Safaa Sebak, Jasmine Bhathena, Satya <strong>Prakash*</strong> (2008). RNA I congress, April 30-2 May , Boston U.S.A. </p>
							</li>
							<li>
								<p class="auto-style7">Kulamarva, Arun Malhotra Meenakshi, Bhathena Jasmine, Sebak Safaa an <strong>Prakash*</strong>, Satya (2008).&nbsp;In-vitro evaluation of carbon nanotube mediated gene delivery for colon cancer. NSTI Nanotechnology Conference and Trade Show, June 1-5, Boston, U.S.A. </p>
							</li>
							<li>
								<p class="auto-style7">Safaa Sebak, Maryam Mirzaei, Meenakshi Malhotra, Arun Kulamrava and Satya <strong>Prakash*</strong> (2008). Human Serum Albumin Nano devices as efficient drug delivery systems. 8th Annual McGill Biomedical Graduate Conference. February 26, Montreal, Canada.</p>
							</li>
							<li>
								<p class="auto-style7">Kulamarva, Arun Malhotra Meenakshi, Bhathena Jasmine, Sebak Safaa and <strong>Prakash*</strong>, Satya (2008). In-vitro cytotoxicity of functionalized single walled carbon nanotubes for targeted gene delivery applications. International Conference on Nanomaterial Toxicology, Feb 4-8, Lucknow, India.</p>
							</li>
							<li>
								<p class="auto-style7">Malhotra M, Kulamarva A, Sebak S, Bhathena J,  <strong>Prakash*</strong>, S. (2008)Cationic chitosans as efficient non-viral nano-carriers for gene delivery. 31 st Canadian Medical and Biological  Engineering Conference (CMBEC31), June 11-13, Montreal, Canada.</p>
							</li>
							<li>
								<p class="auto-style7">Malhotra M, Kulamarva A, Sebak S, Bhathena J, <strong>Prakash*</strong>, S. (2008) In vitro transfection efficiency of chitosan nanoparticles for gene delivery NSTI Nanotech 2008, June1-5, Boston Massachusetts, USA.</p>
							</li>
							<li>
								<p class="auto-style7">Malhotra M, Kulamarva A, Sebak S, Bhathena J,<strong>Prakash*</strong>, S. (2008). Characterization of low molecular weight chitosan nanoparticles as a delivery carrier for therapeutic molecules 8 th Annual McGill Biomedical Graduate Conference. February 26, Montreal, Canada.</p>
							</li>
							<li>
								<p class="auto-style7">Martoni, C., Bhathena, J., <strong>Prakash</strong>, S. (2008). 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology. Barcelona, Spain.</p>
							</li>
							<li>
								<p class="auto-style7">Martoni, C., Bhathena, J., Urbanska, A., <strong>Prakash</strong>, S. (2008) 8th World Biomaterials Congress. Amsterdam, Netherlands. </p>
							</li>
							<li>
								<p class="auto-style7">Urbanska AM , Bhathena J, Martoni C, Kulamarva A and <strong>Prakash</strong> S., (2007) Estimation of the potential antitumor activity of microencapsulated Lactobacillus acidophilus yogurt formulation in the progression of colon cancer in Apc(Min/+) mice, Singapore, (Dec.10-12). </p>
							</li>
							<li>
								<p class="auto-style7">Bhathena J., Kulamarva A, Urbanska A.M, Martoni C and <strong>Prakash*</strong>, S. (2007) Preparation and in-vitro analysis of microencapsulated bacterial cells for biotechnological production of ferulic acid. The Pacific Rim Summit on Industrial Biotechnology and Bioenergy. Honolulu, Hawaii, USA. </p>
							</li>
							<li>
								<p class="auto-style7">Al-Kindi, A., Chen, S.Y., Asento, J.F., Ge, Y., Bhathena, J., Chiu, R.C.J., <strong>Prakash*</strong>, S., Shum-Tim*, D. (2007). Microencapsulation to reduce mechanical loss of microspheres: implications in myocardial cell therapy. Canadian Cardiovascular Congress 2007, Quebec City, Canada. </p>
							</li>
							<li>
								<p class="auto-style7">Malhotra Meenakshi, Kulamarva Arun, Sebak Safaa, Bhathena Jasmine, Mirzaei Maryam,<strong>Prakash*</strong>, Satya (2007). Nanoparticles for targeted delivery of therapeutic molecules for use in neurodegenerative diseases International Conference of Neurons and Brain Disease, August 29-31, University of Toronto, Canada. </p>
							</li>
							<li>
								<p class="auto-style7">Malhotra Meenakshi, Kulamarva Arun, Sebak Safaa, Bhathena Jasmine, Mirzaei Maryam, <strong>Prakash*</strong>, Satya (2007). Optimizing the design principles of cationic chitosan nanoparticles as an efficient gene delivery system 2nd Annual Conference of the CSLSR, July 13-14, 2007, McGill University, Montreal, QC, Canada. </p>
							</li>
							<li>
								<p class="auto-style7">Malhotra Meenakshi, Kulamarva Arun, Sebak Safaa, Bhathena Jasmine, Mirzaei Maryam, <strong>Prakash*</strong>, Satya (2007). Optimizing the design principles of cationic chitosan nano carriers for efficient biocompatible delivery system.Virtual conference on Nanoscale Science and Technology, VC-NST, October 21-25. </p>
							</li>
							<li>
								<p class="auto-style7">Al-Kindi, A., Chen, S.Y., Asento, J.F., Ge, Y., Bhathena, J., Chiu, R.C.J., <strong>Prakash*</strong>, S., Shum-Tim*, D. (2007) Cellular cardiomyoplasty: Optimizing cellular dosage and retention by microencapsulation. American Heart Association Scientific Sessions 2007. Orlando, Florida, USA. </p>
							</li>
							<li>
								<p class="auto-style7">Safaa Sebak, Maryam Mirzaei, Meenakshi Malhotra, Arun Kulamarva and Satya <strong>Prakash*</strong> (2007). Characterization and Optimization of Human Serum Albumin Nanocapsules for Drug Delivery Applications. International Congress of Nanotechnology, San Francisco, CA, USA. </p>
							</li>
							<li>
								<p class="auto-style7">Safaa Sebak, Maryam Mirzaei, Meenakshi Malhotra, Arun Kulamarva and Satya <strong>Prakash*</strong> (2007). Design and Characterization of Human Serum Albumin Nanoparticles for Drug Delivery Applications, Virtual Conference on Nanoscale Science and Technology, Fayetteville, AR, USA.</p>
							</li>
							<li>
								<p class="auto-style7">Safaa Sebak, Maryam Mirzaei, Meenakshi Malhotra, Arun Kulamarva and Satya <strong>Prakash*</strong> (2007). Preparation and Characterization of Human Serum Albumin Nanoparticles for Drug Delivery Applications, Abstract in Canadian Society for Life Science Research, Montreal, Canada. Won the &ldquo;best paper award&rdquo;.</p>
							</li>
							<li>
								<p class="auto-style7">Maryam Mirzaei , Barabara Jardin, Satya <strong>Prakash*</strong>,and Cynthia Elias (2007). Production of human Interleukin-7 in stably transfected Spodoptera frugiperda (Sf9) insect cells. Abstract, Canadian Society for Pharmaceutical Sciences (May 31- June 1). Funding: CIHR.</p>
							</li>
							<li>
								<p class="auto-style7">M. Mirzaei, S. <strong>Prakash*</strong> and C.B. Elias and (2007). Expression of Human Interleuhin-7 in insect cells. Abstract, National Biotechnology Conference, June 24-27. San Diego, CA, USA. Funding: CIHR</p>
							</li>
							<li>
								<p class="auto-style7">Urbanska AM , Bhathena J, and <strong>Prakash</strong> S., (2007) APA microencapsulated probiotic Lactobacillus acidophilus cells serve as enhanced delivery method to the intestines, BIO International Convention, Boston, USA (May 6-9).</p>
							</li>
							<li>
								<p class="auto-style7">Aleksandra Malgorzata Urbanska, Christopher Martoni, Jasmine Bhathena and Satya <strong>Prakash*</strong> (2006). Microencapsulated live Lactobacillus acidophilus cells improve probiotic delivery to the intestine. Infections and digestive tract diseases Paris, December 7-8, France, Funding: NSERC. </p>
							</li>
							<li>
								<p class="auto-style7">Maryam Mirzaei , Satya <strong>Prakash</strong> and Cynthia Elias (2006) Expression and Purification Of Human Interleuhin-7 In Insect Cells Using Baculovirus Expression System&rdquo; Cell Culture Engineering X, April 23 - 28, Whistler, BC, Canada. </p>
							</li>
							<li>
								<p class="auto-style7">Satya <strong>Prakash*</strong> (2006). Designing Micro, macro, nano artificial cells: potential and limitation. Abstract Frontiers in Nanoscience, Technology and Education, Aug 16-19, Cochin India. Funding: CIHR.</p>
							</li>
							<li>
								<p class="auto-style7">Aleksandra Malgorzata Urbanska, Christopher Martoni, Jasmine Bhathena and Satya <strong>Prakash*</strong> (2006). Potential of yogurt in delivery of live probiotic AC encapsulated cells: in vitro analysis in computer controlled GI model.World congress on industrial biotech and bioprocessing, Toronto, ON, Canada. </p>
							</li>
							<li>
								<p class="auto-style7">Aleksandra Malgorzata Urbanska, Christopher Martoni, Jasmine Bhathena and Satya <strong>Prakash*</strong> (2006). Micorocapsule Lactobacillus acidophilus cells yogurt formulation and its implications in oral therapeutic probiotic cell delivery: preparation and in-vitro analysis. Third NHP Research Conference, March 3-5, Toronto. Receive Best Paper Prize.</p>
							</li>
							<li>
								<p class="auto-style7">M. Mirazai , C.B. Elias and S. <strong>Prakash*</strong> (2005). Expression and purification of Human Interleuhin-7 in insect cells using baculovirus expression system. Abstract, Meeting Baclovirus, San Francisco, CA, USA.</p>
							</li>
							<li>
								<p class="auto-style7">T. Halim, A. Kulamarva, F. Afkhami, and S.<strong>Prakash*</strong> (2005) Metabolic Induction of Probiotic Bacteria for Urea Uptake Applications in Encapsulation and Oral Administration as an Adjunct for Kidney Failure. Abstract, Biomedical Engineering Conference, Singapore. Received &ldquo;outstanding paper award&rdquo; in biomedical engineering.</p>
							</li>
							<li>
								<p class="auto-style7">Hongmei Chen, Wei Ouyang, Fatemeh Afkhamizarreh, Trisnawati Halim and Satya <strong>Prakash*</strong> (2005). In-vitro evaluation of covalently cross-linked microcapsules for oral delivery of live bacteria. Abstract, Biomedical Engineering Conference, Singapore. </p>
							</li>
							<li>
								<p class="auto-style7">F. Afkhami , W. Ouyang, H. Chen, J. Bhathena, T. Halim, and S. <strong>Prakash*</strong> (2005) Oral administration of microcapsules have no impact of GI flora: in vitro analysis using APPPA and APA microcapsules. Abstract, Razi Biomedical Research Conference, Iran. </p>
							</li>
							<li>
								<p class="auto-style7">Aleksandra Malgorzata Urbanska, Christopher Martoni, Jasmine Bhathena and Satya <strong>Prakash*</strong> (2005). Microencapsulation of Lactobacillus acidophilus improves probiotic delivery to the intestine. Abstract Eurobio conference (Oct). Poland. Receive Best Research Award.</p>
							</li>
							<li>
								<p class="auto-style7">F. Afkhami, W. Ouyang, H. Chen, J. Bhathena, T. Halim, and S. <strong>Prakash*</strong>(2005). In vitro analysis of APPPA microcapsules for oral delivery: impact of microcapsules on GI model flora. Abstract European Society for Artificial Organs, Bolona, (Oct), Italy.</p>
							</li>
							<li>
								<p class="auto-style7">T. Halim, W. Ouyang, H.M. Chen, C. Martoni, F. Afkhami and S.<strong>Prakash*</strong> (2005). Activated Charcoal and Probiotic Bacteria in Microcapsules for Creatinine Reduction - Adjunct Therapy for Kidney Failure. Abstract European Society for Artificial Organs, Bolona, (Oct), Italy.</p>
							</li>
							<li>
								<p class="auto-style7">W. Ouyang, F. Afkhami, H. Chen and S.<strong>Prakash*</strong> (2005). Confocal laser scan microscopy (CLSM) for potential microcapsule membrane characterization. Abstract European Society for Artificial Organs, Bolona, (Oct), Italy.</p>
							</li>
							<li>
								<p class="auto-style7">S.<strong>Prakash*</strong> (2005). Artificial cell thalidomide oral targeted delivery for use in Crohn&rsquo;s diseases. Abstract, American Association of Cancer Research meeting, July 18-23. 2005. Anaheim, CA.USA. </p>
							</li>
							<li>
								<p class="auto-style7">Urbenska et al and S. <strong>Prakash*</strong> (2005). Towards a novel therapy for colon cancer: viability of microencapsulated Lactobacillus acidophilus in yogurt as a delivery system. Abstract. American Association of Pharmaceutical Science, National Biotechnology Conference (May), San Francisco, CA.USA. Selected for media presentations (CNN).</p>
							</li>
							<li>
								<p class="auto-style7">S. <strong>Prakash*</strong> (2004). Artificial cells for oral delivery of live bacterial cells for therapy. Abstract in Chemistry Biology Interface: Synergistic New Frontiers (CBISNF 2004), New Delhi, (Nov. 26-28), India.</p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash*</strong>, S. (2004). Artificial cells for oral delivery of live bacterial cells as organ substitute: potentials and limitations. Abstract XXXI Congress of the ESAO. Towards Medical Technology of the Future, (Sept 8-14), Poland</p>
							</li>
							<li>
								<p class="auto-style7">Haque T., H. Chen, W. Ouyang, T. Metz, C. Martoni, and S. <strong>Prakash*</strong> (2004). Design of a new microcapsule membrane combining alginate, chitosan, polyethylene glycol and poly-l-lysine for cell transplantation. Abstract, XXXI Congress of the ESAO. Towards Medical Technology of the Future, (Sept 8-14), Poland.</p>
							</li>
							<li>
								<p class="auto-style7"> Haque Tasima, Hongmei Chen, Wei Ouyang, Terrence Metz, Christopher Martoni, and Satya <strong>Prakash*</strong> (2004). Investigation of a novel microcapsule membrane integrating polyethylene glycol to alginate, poly-l-lysine and chitosan microcapsules for the application of liver cell transplantation. Abstract, XX International Congress of the Transplantation Society, 5-10 September 2004, Vienna. </p>
							</li>
							<li>
								<p class="auto-style7">Satya <strong>Prakash*</strong> (2004). Artificial cells for oral delivery of live bacterial cells as organ substitute: potentials and limitations. Abstract XXXI Congress of the ESAO Towards Medical Technology of the Future, (Sept 8-14), Poland. </p>
							</li>
							<li>
								<p class="auto-style7">Metz ,Terrence Devendra Amre *, Mitchell L. Jones, Wei Ouyang, Hongmei Chen, Tasima Haque Christopher Martoni, and Satya <strong>Prakash*</strong> (2004). Artificial cell microcapsule containing Thalidomide as an alternative oral therapy method for Crohn&rsquo;s Disease (CD). Abstract, Gastroenterology congress 2004, USA. </p>
							</li>
							<li>
								<p class="auto-style7">Metz Terrence, Devendra Amre *, Mitchell L. Jones, Wei Ouyang, Hongmei Chen, Tasima Haque Christopher Martoni, and Satya <strong>Prakash*</strong>< (2004). Artificial cell microcapsule containing Thalidomide as an alternative oral therapy method for Crohn&rsquo;s Disease (CD). Abstract, World congress Paris, France. </p>
							</li>
							<li>
								<p class="auto-style7">Metz Terrence Hongmei Chen, Wei Ouyang, Mitch Lawrence Jones and Satya <strong>Prakash*</strong> (2003). Polymer microcapsules for targeted oral drug delivery in Crohn&rsquo;s disease. Abstract. Canadian Biomaterial Society Meeting, Montreal, Canada. Received 3rd Prize for student paper competitions.</p>
							</li>
							<li>
								<p class="auto-style7">Chen Hongmei, Wei Ouyang Terrence Metz, Mitch Lawrence Jones and Satya <strong>Prakash*</strong> (2003). Alginate-chitosan microcapsules cross-linked by naturally occurring genipin. Abstract. Canadian Biomaterial Society Meeting, Montreal, Canada. </p>
							</li>
							<li>
								<p class="auto-style7">Wei Ouyang, Hongmei Chen, Mitchell Jones, Terrence Metz, and Satya <strong>Prakash*</strong> (2003). Novel multilayer microcapsule and its GI stability. Abstract, 23rd CBS Symposium. Montreal, Quebec, Canada.</p>
							</li>
							<li>
								<p class="auto-style7">Chen, H. M , Ouyang, W. et al. and S. <strong>Prakash*</strong> (2003). Stability of APA microcapsules and their resistance to simulated GI fluids. Abstract. 6 th CBGRC. Montreal, Quebec, Canada.</p>
							</li>
							<li>
								<p class="auto-style7">Jones, M., Chen, H. M., Ouyang, W., Metz, T. and  <strong>Prakash*</strong>, S. (2003). Deconjugation of bile acids with immobilized genetically engineered Lactobacillus Plantarum 80 (pCBH1)  cells and their potential for live cell therapy. Abstract 6th International Congress of the Cell Transplant Society. Atlanta, Georgia, USA.</p>
							</li>
							<li>
								<p class="auto-style7">Chen Hongmei, Ouyang Wei, Jones Mitch Lawrence, Metz Terrence, <strong>Prakash*</strong> Satya (2002). Preparation alginate/chitosan based multilayer microcapsules for biomedical application. Polymer in medicine and Biology, Abstract. American Chemical Society Symposia, California, USA. </span></p>
							</li>
							<li>
								<p class="auto-style7">Wei Ouyang, Hongmei Chen, Terrence Metz, Mitch Lawrence, Jones and Satya <strong>Prakash*</strong> (2002). Novel artificial cell formulation: design, preparation and morphology studies. Abstract. Polymers in Medicine and Biology, USA. </p>
							</li>
							<li>
								<p class="auto-style7">Hongmei Chen, Wei Ouyang Terrence Metz, Mitch Lawrence Jones and Satya <strong>Prakash*</strong> (2002). Ginipin can be used to cross linked alginate and chitosan for improved GI stable microcapsule, Abstract, Concordia University Research Day, Montreal, Canada.</p>
							</li>
							<li>
								<p class="auto-style7"><strong>Prakash*</strong> S. and M. Jones (2002). Engineering artificial cells for cell therapy. Abstract. 2 nd world engineering congress, Malaysia. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Chang, T.M.S. (2001). Artificial cells for lowering plasma metabolites and electrolytes. Abstract, International Symposia on Artificial Organs, NY. USA.</p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Chang, T.M.S. (2000). Abstract China- Canadian Biotechnology meet, (April). Vancouver, B.C., Canada. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Chang, T.M.S. (1998). Abstract in International Symposia on Frontiers in Biomedical Engineering (Aug.), New Delhi, India.</p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Chang, T.M.S. (1997). Abstract International Symposium on Uremic Toxicity, (April.). Nagoya , Japan. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Chang, T.M.S. (1995). Abstract 17th Annual International Conference IEEE Engineering in Medicine and Biology and the 21st Canadian Medical and Biological Engineering Conference, (Sept.). Montreal, Quebec, Canada.</p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Chang, T.M.S. (1994). Abstract XI congress of the Society of the Artificial Cells, Blood Substitute and Immobilization Biotechnology, (July 24).MIT, Boston. Massachusetts, USA. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Chang, T.M.S. (1994). Microencapsulated bacteria for uremia. Abstract China-Canada Biotechnology Conference, (May 8-11). Tianjin, Peoples Republic of China. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash</strong>, S. and Kundu, S. (1989). Bioleaching of copper. Abstract in International Symposia on bio-hydrometallurgy, August). Jackson, Wyoming, USA.</p>
							</li>
						</ol>
		    	</div>

		    	<div class="tab-pane fade" id="pill-refPro" role="tabpanel" aria-labelledby="pill-refPro-tab">
					<h1 class="mt-2 mb-2">Refereed proceedings</h1>
					<hr>
						<ol>
							<li>
								<p class="auto-style7">Al-Kindi, A., Chen, G., Ge, Y., Bhathena, J., Chiu, R., <strong>Prakash*</strong>, S., Shum-Tim, D. (2007) Microencapsulated stem cell retention for localized cardiac cell delivery. Canadian Journal of Cardiology; Vol. 23:77C.</p>
							</li>
							<li>
								<p class="auto-style7">Tasima Haque, Hongmei Chen, Wei Ouyang, Terrence Metz, Bisi Lawuyi, Satya  <strong>Prakash*</strong> (2004) Effect of integrating polyethylene glycol to alginate-poly-l-lysine and alginate chitosan microcapsules for oral delivery of live cells and cell transplant for therapy, Proc. CMBEC28, Quebec, Canada, pp. 164-167. </p>
							</li>
							<li>
								<p class="auto-style7">Tasima Haque, Hongmei Chen, Wei Ouyang, Christopher Martoni, and Satya <strong>Prakash*</strong> (2004). Design of a novel microcapsule membrane combining alginate, chitosan, polyethylene glycol and poly-l-lysine for cell transplantation. Proc. ESIAO, International Journal of Artificial Organs Vol. 27, No.7, page 609. </p>
							</li>
							<li>
								<p class="auto-style7">S.  <strong>Prakash*</strong> (2004). Artificial cells for oral delivery of live bacterial cells as organ substitute: potentials and limitations. Proc. ESIO, Journal of International Artificial Organs, Vol. 27, No.7, page 591.</p>
							</li>
							<li>
								<p class="auto-style7">Chen, H. M., Ouyang, W., Jones, M., Tasima Haque, Bisi Lawuyi, Aleksandra Urbanska and  <strong>Prakash*</strong> , S. (2004) In-vitro characterization of APA microcapsules for oral delivery of live bacterial cells. Proc. CMBEC28, Quebec, Canada, pp. 172-175. </p>
							</li>
							<li>
								<p class="auto-style7">M.L. Jones, C. Martoni, H. Chen, W.Ouyang, T. Metz, and S. <strong>Prakash*</strong>  (2003). Proceeding 6 th International Congress of the Cell Transplant Society page 6-9.</p>
							</li>
							<li>
								<p class="auto-style7">S.  <strong>Prakash*</strong>  and M. L. Jones: (2002). Artificial cells for cell therapy. Proceeding 2 nd world engineering congress, 2, 206-208. </p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash*</strong>, S. and Chang, T.M.S. (1997). Proceedings 3 rd International Symposium on Uremic Toxicity, Nagoya, Japan (April.).</p>
							</li>
							<li>
								<p class="auto-style7"> <strong>Prakash*</strong>, S. and Chang*, T.M.S. (1995). Proceedings 17th Annual International Conference IEEE Engineering in Medicine and Biology and the 21st Canadian Medical and Biological Engineering Conference, Montreal, Quebec, Canada (Sept.). </p>
							</li>
						</ol>
		    	</div>

		    	<div class="tab-pane fade" id="pill-talks" role="tabpanel" aria-labelledby="pill-talks-tab">
					<h1 class="mt-2 mb-2">Invited Talks</h1>
					<hr>
						<ol>
							<li>
								<p class="auto-style7">&ldquo;Session chair and  invited speaker&rdquo; on &ldquo;MicroProbiotic Health Food: Hypercholesterolemia&rdquo;. IIIT,  Allahabad, India Inspired Program. Very prestigious meeting where 7 Noble  Prize Laureates are participating. Microbiome and human health with emphasis on  heart health. (Dec 8-14, 2012). </p>
							</li>
							<li>
								<p class="auto-style7">Session Chair: Health  Food Section.&nbsp; Natural Health Product Society Meeting, Kalona, B.C.,  Canada. May 18-25. 2012.</p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker: Novel  NO gas probiotic device at &ldquo;Bay Area Biomedical Technology Conference 2012.  March. San Jos&eacute;e California, USA. </p>
							</li>
							<li>
								<p class="auto-style7">&ldquo;Session chair and  invited speaker&rdquo; on &ldquo;Probiotic Health Food: Hypercholesterolemia&rdquo;. IIIT,  Allahabad, India Inspired Program. Very prestigious meeting where 10 Noble  Prize Laureates are participating in this event. (Nov. 28-3 Dec, 2011). </p>
							</li>
							<li>
								<p class="auto-style7">&ldquo;Invited speaker&rdquo; on  insect cell protein engineering at &ldquo;Protein Expression Group Meeting&rdquo;. May 18,  (2011), Boston, USA.</p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker: on  probiotics for colon cancer prevention/therapy at &ldquo;Bay Area Biomedical  Technology Conference 2011. May 8, 2011. San Jos&eacute;e, California, USA. </p>
							</li>
							<li>
								<p class="auto-style7">&quot;Session chair and invited speaker&#8221; on &#8220;Probiotic hypercholesterolemia&#8221;. IIIT, Allahabad, India Inspired Program. Very prestigious meeting where  10 Noble Prize Laureates will participate. (Dec. 8-13, 2010). </p>
							</li>
							<li>
								<p class="auto-style7">Invited Speaker on &#8220;Probiotics colon cancer&#8221;, Texas Women&#8217;s University, USA (Oct, 2010).</p>
							</li>
							<li>
								<p class="auto-style7">Invited Speaker at Probiotics at International Society for Functional Food &amp; Nutraceuticals meeting, Bali (Oct, 2010).</p>
							</li>
							<li>
								<p class="auto-style7">Invited Speaker on &#8220;Colon cancer biomedicine&#8221; at Biomed 2010, Istanbul. Turkey (Oct 2010).</p>
							</li>
							<li>
								<p class="auto-style7">Invited Speaker on &#8220;Novel carbon nanotube delivery system&#8221; at Nanomedicine Conference, Antalya. Turkey (Oct 2010).</p>
							</li>
							<li>
								<p class="auto-style7">Invited Speaker and session co-chair at Bio- and Nanotech Conference, Portugal (2010). </p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker on &#8220;Microencapsulated probiotics: Bacterial cells for colon cancer prevention and therapy&#8221;. ACS 239th National Meeting, San Francisco, USA (March, 2010).</p>
							</li>
							<li>
								<p class="auto-style7">&#8220;Session chair and invited speaker&#8221; on &#8220;Probiotic hypercholesterolemia&#8221;. IIIT Inspired Program. Very prestigious meeting where 14 Noble Prize Laureates participated. (Dec. 2009). </p>
							</li>
							<li>
								<p class="auto-style7">&#8220;Session chair and invited speaker&#8221; on &#8220;Bio-therapeutics for hypercholesterolemia&#8221;. World congress on Gene. Very prestigious meeting where 3 Noble Prize Laureates (Dr. A. Ciechanover, Nobel Laureate, Chemistry, 2004; Dr. R. R. Ernst, Nobel Laureate, Chemistry, 1991 and Dr. R. Huber Nobel Laureate, Chemistry, 1988) participated. (Dec. 2009). </p>
							</li>
							<li>
								<p class="auto-style7">&#8220;Keynote Speaker&#8221;. International Society for Functional Food &amp; Nutraceuticals meeting, San Francisco, USA. (Nov, 2009).</p>
							</li>
							<li>
								<p class="auto-style7">Invited Speaker on-&#8220;Microencapsulation and artificial organs&#8221; at European Society for Artificial Organs Congress (ESAO). Compiegne, France. (Sept., 2009).</p>
							</li>
							<li>
								<p class="auto-style7">&#8220;Invited Speaker&#8221; on-&#8220;Microencapsulation probiotics for colon cancer prevention therapy&#8221; European Society for Artificial Organs Congress (ESAO). Compiegne, France. (Sept., 2009).</p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker on- Non-viral production of human interleukin-7 in spodoptera frugiperda insect cells as a soluble recombinant protein. Specialized Protein Expression Systems Conference, Cambridge, Massachusetts, USA (Aug., 2009).</p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker and job counseling committee member, Society for industrial microbiology Annual Meeting and Exhibition, Toronto, Canada (July 26-30, 2009).</p>
							</li>
							<li>
								<p class="auto-style7">&#8220;Breakout session&#8221; chair and Invited speaker on-Probiotic Food Ingredients and Pharmaceuticals. World Congress on Industrial Biotechnology and Bio-processing Montreal, Canada. More than 4000 participants. (July, 2009). </p>
							</li>
							<li>
								<p class="auto-style7">&#8220;Keynote&#8221; speaker on-&#8220;Novel microcapsule carbon nanotube devices&#8221; at New Jersey Technology Council Annual Conference. The New Jersey is a private nonprofit organization that represents over 1000 technology companies in NJ, NY and PA (March 2009).</p>
							</li>
							<li>
								<p class="auto-style7">&#8220;Keynote speaker&#8221; on-&#8220;Novel microcapsule carbon nanotube devices&#8221; at New Jersey Technology Council Annual Conference. The New Jersey is a private nonprofit organization that represents over 1000 technology companies in NJ, NY and PA. (March 2009).</p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker on- &#8220;Microencapsulation&#8221; at Dept. of Medicinal Chemistry, Faculty of Medicine, Banaras Hindu University, India (Feb, 2009).</p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker on-&#8220;Cholesterol management: probiotics&#8221; at Dept. of Zoology, Faculty of Science, Gorakhpur University, India (Feb, 2009).</p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker and Panel member Career in Biomedical Engineering. Faculty of Eng. McGill University, Montreal, Canada. (Jan, 2009).</p>
							</li>
							<li>
								<p class="auto-style7">Invited Speaker, Canada-India Nanotechnology Meet 2008: University of Montreal, Quebec, Canada. (July, 2008).</p>
							</li>
							<li>
								<p class="auto-style7">Invited symposia closing ceremony Speaker, Probiotech 2008: Nantes, France. (June, 2008).</p>
							</li>
							<li>
								<p class="auto-style7">Invited Speaker and exchange visit The First  People's Hospital of Xuzhou, Xuzhou, Jiangsu 221000, People Republic  of China (May, 2008).</p>
							</li>
							<li>
								<p class="auto-style7">Invited Speaker and exchange visit Sanjiu Medical &amp; Pharmaceutical Company Yinhu Shenzhen, China, 518029, People Republic of China (May, 2008).</p>
							</li>
							<li>
								<p class="auto-style7">Invited Speaker and visited, Unihealth China Qingdao, 266071, People Republic of China (May, 2008).</p>
							</li>
							<li>
								<p class="auto-style7">Invited Speaker and exchange visit he HuaiHua  Medical College, Huaihua, Hunan 418000, People Republic of China (May, 2008).</p>
							</li>
							<li>
								<p class="auto-style7">Invited Speaker the 999 Group Ningbo Medicine Co., Yinhu Shenzhen, China, (May, 2008).</p>
							</li>
							<li>
								<p class="auto-style7">Invited Speaker. Cytotoxicity of Carbon Nanotubes. International Conference on Nano toxicity, Lucknow, India (Feb, 2008).</p>
							</li>
							<li>
								<p class="auto-style7">Invited Speaker. University of Delhi, Dept of Chemistry, India (Feb, 2008).</p>
							</li>
							<li>
								<p class="auto-style7">Invited Speaker. Banaras Hindu University, Dept of Aurbeda, India (Feb, 2008).</p>
							</li>							
							<li>
								<p class="auto-style7">Invited Speaker. Probiotics, Prebiotics, Symbiotics and Functional Food: Scientific and Clinical Aspects, St Petersburg, Russia (May, 2007).</p>
							</li>
							<li>
								<p class="auto-style7">Invited Speaker. Frontiers in Nanoscience, Technology and Education, Cochin, India (Aug, 2006).</p>
							</li>

							<li>
								<p class="auto-style7">Invited Speaker and exchange visit Zhejiang University, China (Oct, 2005).</p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker and session chair, 3rd Annual Congress of International Drug Discovery Science and Technology (IDDST) 2005 organized by World High Technology Society (WHTS), Shanghai, P.R. of China. (October, 2005).</p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker. Microencapsulation of L. acidophilus  improves probiotic delivery to the intestine. Eurobio Conference, Krakove, Poland (Nov, 2005).</p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker. Institute of Cybernatics,  Warsaw, Poland (Nov, 2005).</p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker. In vitro analysis of APPPA microcapsules for oral delivery: impact of microcapsules on GI model flora. European Society for Artificial Organs, Bolona, Italy (Oct, 2005).</p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker. Artificial cell thalidomide oral targeted delivery for use in Crohn&rsquo;s diseases. American Association of Cancer Research (AACR) meeting, 2005. Anaheim, CA.USA. (July, 2005).</p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker as an expert on artificial  cells for oral delivery of live bacterial cells for therapy. Chemistry Biology Interface: Synergistic New Frontiers (CBISNF, 2004), New Delhi, India (Nov., 2004).</p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker as an expert on artificial cells for oral delivery of live bacterial cells as organ substitute: potentials and limitations. XXXI Congress of the European Society for  Artificial Organs (ESAO) Towards Medical Technology of the Future, Poland, (Sept, 2004).</p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker as an expert on cell therapy and tissue engineering in Disruptive Technologies Workshop (CIHR, NRC, NSERC strategy planning for year 2040), Ottawa, Canada. (Feb.2004).</p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker. The life of a professor: a  panel discussion. Thomson House McGill University, Montreal, Canada.(Feb,3, 2003).</p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker, Anatomy and Cell Biology, McGill, Montreal, Canada. (Jan 2002).</p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker at 2 nd World Engineering Congress, Malaysia (July, 2002). </p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker at the China-Canada Biotechnology Conference, UBC, Vancouver, Canada (April, 2000). </p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker at Innovation and Trends in Biotechnology (ITB) conference sponsored by Quebec Biotechnology Association, Quebec, Canada (April,1999).</p>
							</li>
							<li>
								<p class="auto-style7">Invited Speaker at Technical Univ. of Gdansk (Politechnika Gdanska) Ul. Narutowicza, Gdansk, Wrzeszcz, Poland (June, 1998). </p>
							</li>
							<li>
								<p class="auto-style7">Invited Speaker Department third international seminar on statistics and clinical practice at Institute of Biocybernetics and Biomedical Warsaw (45th seminar of the international center of biocybernetics Poland (June, 1998). </p>
							</li>
							<li>
								<p class="auto-style7">Opening Speaker Platinum Jubilee Celebration, a Symposium on Frontiers in Biomedical Research at Delhi University, India (April, 1998).</p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker at the international symposia on Frontiers in Biomedical Research, New Delhi, India (April, 1998).</p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker5, Dept. of Pharmacology, Univ. of Chicago, USA (Aug 1997). </p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker at ASTRA Biotech. Ltd. Montreal, Quebec, Canada (Jan., 1997). </p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker at the Nephrology Conference Series, Royal Victoria Hospital, McGill University, Montreal, Canada (Feb. 1997). </p>
							</li>
							<li>
								<p class="auto-style7">Invited Speaker at the Department Of Endocrinology Institute of Obstetrics and Gynecology Medical University, Kliniczna, Poland (June, 1997). </p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker, Meakins-Chistie Laboratories, McGill University, Montreal, Quebec, Canada (April, 1997). </p>
							</li>
							<li>
								<p class="auto-style7">Opening speaker for &quot;State of Art Lecture Series&quot; at 3rd International symposia on uremia. (April 1997). Japan. </p>
							</li>
							<li>
								<p class="auto-style7">Session Chairman for Uremic complications at 3rd International symposia on uremia, Japan. (April 1997). </p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker at World Congress of Biomedical Engineers sponsored by IEEE and CMBE, Montreal, Canada (Sept, 1995).</p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker, China-Canada Biotech. Meet, Nankai Univ., China (May, 94). </p>
							</li>
							<li>
								<p class="auto-style7">Invited speaker at XI Congress of the International Society of Artificial Cells, Blood Substitute and Immobilization Biotechnology, M.I.T., USA (July, 1993). </p>
							</li>
						</ol>
		      </div>		      
		    </div>
		  </div>
		</div>

	</div>

	<footer class="footer sticky-bottom">
		<p class = 'left'>	
			<span class="footHeading">Find us at:<br></span>
			McGill University <br>
			3775 University Street <br>
			Montréal, QC H3A 2B4 <br>
			Canada <br>
		</p>
		<p class = 'right'>
			<span class="footHeading">Contact us at:<br></span>
			Phone: 1 (514) 398-2736<br>
			Fax: 1 (514) 398-7461 <br> 
		</p>
	</footer>
</body>
	<script src="https://code.jquery.com/jquery-3.5.1.slim.min.js" integrity="sha384-DfXdz2htPH0lsSSs5nCTpuj/zy4C+OGpamoFVy38MVBnE+IbbVYUew+OrCXaRkfj" crossorigin="anonymous"></script>
	<script src="https://cdn.jsdelivr.net/npm/popper.js@1.16.0/dist/umd/popper.min.js" integrity="sha384-Q6E9RHvbIyZFJoft+2mJbHaEWldlvI9IOYy5n3zV9zzTtmI3UksdQRVvoxMfooAo" crossorigin="anonymous"></script>
	<script src="https://stackpath.bootstrapcdn.com/bootstrap/4.5.0/js/bootstrap.min.js" integrity="sha384-OgVRvuATP1z7JjHLkuOU7Xw704+h835Lr+6QL9UvYjZE3Ipu6Tp75j7Bh/kR0JKI" crossorigin="anonymous"></script>
	<script type="text/javascript" src="script.js"></script>
	<script type="text/javascript" src='nav.js'></script>
</html>